Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact

Citations to this article

Anti–spike IgG causes severe acute lung injury by skewing macrophage responses during acute SARS-CoV infection
Li Liu, … , Kwok-Yung Yuen, Zhiwei Chen
Li Liu, … , Kwok-Yung Yuen, Zhiwei Chen
Published February 21, 2019
Citation Information: JCI Insight. 2019;4(4):e123158. https://doi.org/10.1172/jci.insight.123158.
View: Text | PDF
Research Article Infectious disease Pulmonology

Anti–spike IgG causes severe acute lung injury by skewing macrophage responses during acute SARS-CoV infection

  • Text
  • PDF
Abstract

Newly emerging viruses, such as severe acute respiratory syndrome coronavirus (SARS-CoV), Middle Eastern respiratory syndrome CoVs (MERS-CoV), and H7N9, cause fatal acute lung injury (ALI) by driving hypercytokinemia and aggressive inflammation through mechanisms that remain elusive. In SARS-CoV/macaque models, we determined that anti–spike IgG (S-IgG), in productively infected lungs, causes severe ALI by skewing inflammation-resolving response. Alveolar macrophages underwent functional polarization in acutely infected macaques, demonstrating simultaneously both proinflammatory and wound-healing characteristics. The presence of S-IgG prior to viral clearance, however, abrogated wound-healing responses and promoted MCP1 and IL-8 production and proinflammatory monocyte/macrophage recruitment and accumulation. Critically, patients who eventually died of SARS (hereafter referred to as deceased patients) displayed similarly accumulated pulmonary proinflammatory, absence of wound-healing macrophages, and faster neutralizing antibody responses. Their sera enhanced SARS-CoV–induced MCP1 and IL-8 production by human monocyte–derived wound-healing macrophages, whereas blockade of FcγR reduced such effects. Our findings reveal a mechanism responsible for virus-mediated ALI, define a pathological consequence of viral specific antibody response, and provide a potential target for treatment of SARS-CoV or other virus-mediated lung injury.

Authors

Li Liu, Qiang Wei, Qingqing Lin, Jun Fang, Haibo Wang, Hauyee Kwok, Hangying Tang, Kenji Nishiura, Jie Peng, Zhiwu Tan, Tongjin Wu, Ka-Wai Cheung, Kwok-Hung Chan, Xavier Alvarez, Chuan Qin, Andrew Lackner, Stanley Perlman, Kwok-Yung Yuen, Zhiwei Chen

×

Total citations by year

Year: 2025 2024 2023 2022 2021 2020 2019 2009 Total
Citations: 5 18 29 68 183 259 1 1 564
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (565)

Title and authors Publication Year
Antibody-dependent enhancement of coronaviruses
Tao T, Tian L, Ke J, Zhang C, Li M, Xu X, Fan J, Tong Y, Fan H
International Journal of Biological Sciences 2025
Pulmonary Myeloid Cells in Mild Cases of COVID-19 Upregulate the Intracellular Fc Receptor TRIM21 and Transcribe Proteasome-Associated Molecules
Henriques-Pons A, Castro MC, Silva VS, Costa MO, Silva HS, Walter ME, Carvalho AC, Melo AC, Ocaña K, dos Santos MT, Nicolas MF, Silva FA
International Journal of Molecular Sciences 2025
Hamsters immunized with formalin-inactivated SARS-CoV-2 develop accelerated lung histopathological lesions and Th2-biased response following infection
de Jong R, Vreman S, Wiese KE, Gerhards NM, Bewley KR, Hall Y, Salguero FJ, Carroll M, de Swart RL, Gonzales JL, Oreshkova N
NPJ Vaccines 2025
Pulmonary function and comparative SARS-CoV-2 RBD-specific IgG antibody response among the COVID-19 recovered group
Siddik AB, Faisal A, khan AH, Alam MM, Nayeem J, Kulsum U, Mukta SA, Kawser Z, Hasan I, Azad K, Hossain M, Kar S, Sultana N, Alam MR, Mustafa A, Habib MT, Ryan ET, Qadri F, Hassan MR
PLOS One 2025
A Comprehensive Review of mRNA-based Vaccines for COVID-19, A New Era in Pharmaceuticals: Unspecified and Unknown Aspects, Effects and Challenges.
Vosoughi P, Naghib SM, Rahmanian M, Mozafari MR
Current topics in medicinal chemistry 2025
Kinome and phosphoproteome reprogramming underlies the aberrant immune responses in critically ill COVID-19 patients.
Kaneko T, Ezra S, Abdo R, Voss C, Zhong S, Liu X, Hovey O, Slessarev M, Van Nynatten LR, Ye M, Fraser D, Li SS
Clinical Proteomics 2024
The laboratory parameters in predicting the severity and death of COVID-19 patients: Future pandemic readiness strategies
Alsayed AR, Ahmed SI, AL Shweiki AO, Al-Shajlawi M, Hakooz N
2024
Multi-omics analysis reveals COVID-19 vaccine induced attenuation of inflammatory responses during breakthrough disease
Drury RE, Camara S, Chelysheva I, Bibi S, Sanders K, Felle S, Emary K, Phillips D, Voysey M, Ferreira DM, Klenerman P, Gilbert SC, Lambe T, Pollard AJ, O\u2019Connor D
Nature Communications 2024
Adjuvant-dependent impact of inactivated SARS-CoV-2 vaccines during heterologous infection by a SARS-related coronavirus.
Dillard JA, Taft-Benz SA, Knight AC, Anderson EJ, Pressey KD, Parotti B, Martinez SA, Diaz JL, Sarkar S, Madden EA, De la Cruz G, Adams LE, Dinnon KH 3rd, Leist SR, Martinez DR, Schäfer A, Powers JM, Yount BL Jr, Castillo IN, Morales NL, Burdick J, Evangelista MKD, Ralph LM, Pankow NC, Linnertz CL, Lakshmanane P, Montgomery SA, Ferris MT, Baric RS, Baxter VK, Heise MT
Nature Communications 2024
Physicochemical properties-based hybrid machine learning technique for the prediction of SARS-CoV-2 T-cell epitopes as vaccine targets.
Bukhari SNH, Elshiekh E, Abbas M
2024
From Detection to Protection: Antibodies and Their Crucial Role in Diagnosing and Combatting SARS-CoV-2.
Kumar A, Tripathi P, Kumar P, Shekhar R, Pathak R
Human vaccines 2024
Characterization and immunogenicity assessment of MERS-CoV pre-fusion spike trimeric oligomers as vaccine immunogen
Ahuja R, Vishwakarma P, Raj S, Kumar V, Khatri R, Lohiya B, Saxena S, Kaur G, Singh G, Asthana S, Ahmed S, Samal S
Human Vaccines & Immunotherapeutics 2024
No evidence for enhanced disease with human polyclonal SARS-CoV-2 antibody in the ferret model
Reed DS, McElroy AK, Barbeau DJ, McMillen CM, Tilston-Lunel NL, Nambulli S, Cottle E, Gilliland TC, Rannulu H, Lundy J, Olsen EL, O\u2019Malley KJ, Xia M, Hartman AL, Luke TC, Egland K, Bausch C, Wu H, Sullivan EJ, Klimstra WB, Duprex WP
PloS one 2024
Temporal Trends in SARS-CoV-2 Antibody Levels Among COVID-19 Patients in Kerala During the First Wave and Pre-vaccination Period
Mathew JK, Radhakrishnan C, K AB, Philomina BJ, K TN, Dhanasooraj D
Cureus 2024
Differentiating COVID-19 and influenza in children: hemogram parameters as diagnostic tools
Dulkadir R, Oztelcan Gunduz B
Frontiers in public health 2024
Mechanisms of antibody-dependent enhancement of infectious disease.
Wells TJ, Esposito T, Henderson IR, Labzin LI
Nature reviews. Immunology 2024
The Seraph 100® Microbind Affinity Blood Filter Does Not Alter Levels of Circulating or Mucosal Antibodies in Critical COVID-19 Patients
Conner TL, Vir P, Laing ED, Stewart IJ, Mitre E, Pratt KP
Antibodies 2024
Pulmonary Injury as a Complication of Urinary Tract Infection in Pregnancy.
Hafez W, Al Shareef J, Alyoussef A, Ghanem M, Abazid RR, Yadav A, Rashid A, Sayfoo FM, Venkataramani S, Restrepo PO, Elkott MM, Lakshman VS, Arief T, Mohammed AG, Abdulaal F, Hossam Y
International journal of MCH and AIDS 2024
Preclinical assessment of a recombinant RBD-Fc fusion protein as SARS-CoV-2 candidate vaccine
Dashti N, Golsaz-Shirazi F, Soltanghoraee H, Zarnani AH, Mohammadi M, Imani D, Jeddi-Tehrani M, Amiri MM, Shokri F
European Journal of Microbiology & Immunology 2024
Lack of Evidence for Vaccine-Associated Enhanced Disease From COVID-19 Vaccines Among Adults in the Vaccine Safety Datalink
Boyce TG, McClure DL, Hanson KE, Daley MF, DeSilva MB, Irving SA, Jackson LA, Klein NP, Lewin B, Williams JT, Duffy J, McNeil MM, Weintraub ES, Belongia EA
Pharmacoepidemiology and drug safety 2024
Prediction of antigenic peptides of SARS- CoV-2 pathogen using machine learning
Bukhari SN, Ogudo KA
PeerJ Computer Science 2024
Antibodies to the RBD of SARS-CoV-2 spike mediate productive infection of primary human macrophages
Pickering S, Wilson H, Bravo E, Perera MR, Seow J, Graham C, Almeida N, Fotopoulos L, Williams T, Moitra A, Winstone H, Nissen TA, Galão RP, Snell LB, Doores KJ, Malim MH, Neil SJ
Nature Communications 2024
Cellular and immune response in fatal COVID-19 pneumonia
Genova SN, Pencheva MM, Abadjieva TI, Atanasov NG
The Pan African Medical Journal 2024
A receptor-binding domain-based nanoparticle vaccine elicits durable neutralizing antibodies against SARS-CoV-2 and variants of concern
I-Jung Lee, Yu-Hua Lan, Ping-Yi Wu, Yan-Wei Wu, Yu-Hung Chen, Sheng-Che Tseng, Tzu- Kuo, Cheng-Pu Sun, Jia-Tsrong Jan, Hsiu-Hua Ma, Chun-Che Liao, Jian-Jong Liang, Hui- Ko, Chih-Shin Chang, Wen-Chun Liu, Yi-An Ko, Yen-Hui Chen, Zong-Lin Sie, Szu-I Tsung, Yi-Ling Lin, I-Hsuan Wang, Mi-Hua Tao
Emerging Microbes & Infections 2023
Structural insights into broadly neutralizing antibodies elicited by hybrid immunity against SARS-CoV-2.
Luo M, Zhou B, Reddem ER, Tang B, Chen B, Zhou R, Liu H, Liu L, Katsamba PS, Au KK, Man HO, To KK, Yuen KY, Shapiro L, Dang S, Ho DD, Chen Z
Emerging Microbes & Infections 2023
Coagulopathy and the humoral response against viral proteins in patients at different stages of COVID-19
Monteiro FP, Tavares VD, Souza RD, Venâncio LP, Fabres-Klein MH, do Carmo RF, Klein RC, Lima JB, Araújo-Santos T
Memórias do Instituto Oswaldo Cruz 2023
Immunity in SARS-CoV-2 Infection: Clarity or Mystery? A Broader Perspective in the Third Year of a Worldwide Pandemic
Kapten K, Orczyk K, Smolewska E
Archivum Immunologiae et Therapiae Experimentalis 2023
Integrative network pharmacology and in silico analyses identify the anti-omicron SARS-CoV-2 potential of eugenol
Liu Y
Heliyon 2023
Exploring the Role of Immune System and Inflammatory Cytokines in SARS-CoV-2 Induced Lung Disease: A Narrative Review
Tirelli C, De Amici M, Albrici C, Mira S, Nalesso G, Re B, Corsico AG, Mondoni M, Centanni S
Biology 2023
Novel ACE2 fusion protein with adapting activity against SARS-CoV-2 variants in vitro
Zekri L, Ruetalo N, Christie M, Walker C, Manz T, Rammensee HG, Salih HR, Schindler M, Jung G
Frontiers in immunology 2023
A linear SARS-CoV-2 DNA vaccine candidate reduces virus shedding in ferrets.
Martins M, do Nascimento GM, Conforti A, Noll JCG, Impellizeri JA, Sanchez E, Wagner B, Lione L, Salvatori E, Pinto E, Compagnone M, Viscount B, Hayward J, Shorrock C, Aurisicchio L, Diel DG
Archives of Virology 2023
Review of therapeutic mechanisms and applications based on SARS-CoV-2 neutralizing antibodies
Liu M, Gan H, Liang Z, Liu L, Liu Q, Mai Y, Chen H, Lei B, Yu S, Chen H, Zheng P, Sun B
Frontiers in microbiology 2023
In vitro immunogenic profile of recombinant SARS-CoV2 S1-RBD peptide in murine macrophage and microglial cells
Chaves AJ Filho, Jucá PM, Soares MV, de Oliveira CA, de Sousa RC, Lós DB, Russo RC, Yaochite JN, Macedo DS
Memórias do Instituto Oswaldo Cruz 2023
SARS-CoV-2 infection and immune responses
Harne R, Williams B, Abdelal HF, Baldwin SL, Coler RN
AIMS Microbiology 2023
Non-neutralizing antibodies to SARS-Cov-2-related linear epitopes induce psychotic-like behavior in mice
Xu J, Wei H, You P, Sui J, Xiu J, Zhu W, Xu Q
Frontiers in molecular neuroscience 2023
Immunology of SARS-CoV-2 infection and vaccination
Lin B, Cheng L, Zhang J, Yang M, Zhang Y, Liu J, Qin X
Clinica chimica acta; international journal of clinical chemistry 2023
Innate and adaptive immunity to SARS-CoV-2 and predisposing factors
Shen J, Fan J, Zhao Y, Jiang D, Niu Z, Zhang Z, Cao G
Frontiers in immunology 2023
Safety, tolerability, pharmacokinetics, and immunogenicity of an anti-SARS-CoV-2 monoclonal antibody HFB30132A after single dose intravenous administration in healthy Chinese subjects: a phase 1, randomized, double-blind, placebo-controlled study
Li S, Wu X, Li N, Cao G, Wang J, Chen Y, Li S, He J, Wu J, Yang H, Lin K, Qiu C, Liu A, Zhou H, Adrian F, Schweizer L, Zhang W, Gu J, Zhang J
Frontiers in pharmacology 2023
Enhancement of SARS-CoV-2 N Antigen-Specific T Cell Functionality by Modulating the Autophagy-Mediated Signal Pathway in Mice
Wen Z, Yuan Y, Zhao Y, Wang H, Han Z, Li M, Yuan J, Sun C
Viruses 2023
Antibodies Capable of Enhancing SARS-CoV-2 Infection Can Circulate in Patients with Severe COVID-19
Matveev A, Pyankov O, Khlusevich Y, Tyazhelkova O, Emelyanova L, Timofeeva A, Shipovalov A, Chechushkov A, Zaitseva N, Kudrov G, Yusubalieva G, Yussubaliyeva S, Zhukova O, Baklaushev V, Sedykh S, Lifshits G, Tikunov A, Tikunova N
International journal of molecular sciences 2023
LSDV-Vectored SARS-CoV-2 S and N Vaccine Protects against Severe Clinical Disease in Hamsters
de Moor WR, Williamson AL, Schäfer G, Douglass N, Gers S, Sutherland AD, Blumenthal MJ, Margolin E, Shaw ML, Preiser W, Chapman R
Viruses 2023
Antibody-Dependent Enhancement with a Focus on SARS-CoV-2 and Anti-Glycan Antibodies
Ziganshina MM, Shilova NV, Khalturina EO, Dolgushina NV, V. Borisevich S, Yarotskaya EL, Bovin NV, Sukhikh GT
Viruses 2023
SARS-CoV-2 hijacks neutralizing dimeric IgA for nasal infection and injury in Syrian hamsters1
Zhou B, Zhou R, Chan JF, Zeng J, Zhang Q, Yuan S, Liu L, Robinot R, Shan S, Liu N, Ge J, Kwong HY, Zhou D, Xu H, Chan CC, Poon VK, Chu H, Yue M, Kwan KY, Chan CY, Chan CC, Chik KK, Du Z, Au KK, Huang H, Man HO, Cao J, Li C, Wang Z, Zhou J, Song Y, Yeung ML, To KK, Ho DD, Chakrabarti LA, Wang X, Zhang L, Yuen KY, Chen Z
Emerging Microbes & Infections 2023
Refinement of an ovine-based immunoglobulin therapy against SARS-CoV-2, with comparison of whole IgG versus F(ab')(2) fragments.
Findlay-Wilson S, Easterbrook L, Smith S, Pope N, Aldridge M, Humphries G, Schuhmann H, Ngabo D, Rayner E, Otter A, Coleman T, Hicks B, Halkerston R, Apostolakis K, Taylor S, Fotheringham S, Horton A, CanoCejas I, Wand M, Tree JA, Sutton M, Graham V, Hewson R, Dowall S
Scientific Reports 2023
Identification of new drugs to counteract anti-spike IgG-induced hyperinflammation in severe COVID-19
Geyer CE, Chen HJ, Bye AP, Manz XD, Guerra D, Caniels TG, Bijl TP, Griffith GR, Hoepel W, de Taeye SW, Veth J, Vlaar AP, Vidarsson G, Bogaard HJ, Aman J, Gibbins JM, van Gils MJ, de Winther MP, den Dunnen J
Life science alliance 2023
Variant-dependent oxidative and cytokine responses of human neutrophils to SARS-CoV-2 spike protein and anti-spike IgG1 antibodies
Almeida NB, Fantone KM, Sarr D, Ashtiwi NM, Channell S, Grenfell RF, Martins-Filho OA, Rada B
Frontiers in immunology 2023
An inhaled bioadhesive hydrogel to shield non-human primates from SARS-CoV-2 infection
Mei X, Li J, Wang Z, Zhu D, Huang K, Hu S, Popowski KD, Cheng K
Nature Materials 2023
Independent Protection and Influence of the Spike-Specific Antibody Response of SARS-CoV-2 Nucleocapsid Protein (N) in Whole-Virion Vaccines
Yang H, Xie Y, Lu S, Sun Y, Wang K, Li S, Wang J, Liao G, Li C
Human vaccines 2023
Development of AAV-delivered broadly neutralizing anti-human ACE2 antibodies against SARS-CoV-2 variants
Sun CP, Chiu CW, Wu PY, Tsung SI, Lee IJ, Hu CW, Hsu MF, Kuo TJ, Lan YH, Chen LY, Ng HY, Chung MJ, Liao HN, Tseng SC, Lo CH, Chen YJ, Liao CC, Chang CS, Liang JJ, Draczkowski P, Puri S, Chang YC, Huang JS, Chen CC, Kau JH, Chen YH, Liu WC, Wu HC, Danny Hsu ST, Wang IH, Tao MH
Molecular Therapy 2023
PD-L1 expression levels in mesenchymal stromal cells predict their therapeutic values for autoimmune hepatitis
Bai X, Chen T, Li Y, Ge X, Qiu C, Gou H, Wei S, Liu T, Yang W, Yang L, Liang Y, Jia Z, Lv L, Li T
Stem Cell Research & Therapy 2023
SARS-CoV-2 nucleocapsid protein, rather than spike protein, triggers a cytokine storm originating from lung epithelial cells in patients with COVID-19.
Wang YC, Tsai CH, Wang YC, Yen LC, Chang YW, Sun JR, Lin TY, Chiu CH, Chao YC, Chang FY
Infection 2023
The Therapeutic Monoclonal Antibody Bamlanivimab Does Not Enhance SARS-CoV-2 Infection by FcR-Mediated Mechanisms.
Cross RW, Wiethoff CM, Brown-Augsburger P, Berens S, Blackbourne J, Liu L, Wu X, Tetreault J, Dodd C, Sina R, Witcher DR, Newcomb D, Frost D, Wilcox A, Borisevich V, Agans KN, Woolsey C, Prasad AN, Deer DJ, Geisbert JB, Dobias NS, Fenton KA, Strifler B, Ebert P, Higgs R, Beall A, Chanda S, Riva L, Yin X, Geisbert TW
2023
Mitochondria regulate extrafollicular B cell responses to reduce COVID-19 severity
Tianyu Cao, Li Liu, Kelvin To, Chun-Yu Lim, Runhong Zhou, Hallie Kwan, Ming Yue, Sulan Yu, Chun-Yin Chan, Biao Zhou, Haode Huang, Yufei Mo, Zhenglong Du, Ruomei Gong, Luk-Tsz Yat, Ivan Fan-Ngai Hung, Anthony Raymond Tam, Wing-Kin To, Wai-Shing Leung, Thomas Shiu-Hong Chik, Owen Tak-Yin Tsang, Xiang Lin, You-qiang Song, K.Y. Yuen, Zhiwei Chen
Clinical and Translational Medicine 2022
JMJD3 is required for acute pancreatitis and pancreatitis-associated lung injury
Li Chen, Xiangxian Zhang, Yu Liu, Li Liu, Xiao Liang, Shengqun Yang, Qing Xia, Tao Jin, Yun Ma, Yonghua Chen, Xia Yuan, Yan Tie, Yangzhuo Gu, Chunju Fang, Siyuan Chen, Fei Mo, Ting Yu, Yuzhu Hu, Zhiyong Qian, Yong Peng, Jia Geng, Zongguang Zhou, Min Wu, Jiansheng Ding, Daoke Yang, Xiawei Wei
Journal of immunology (Baltimore, Md. : 1950) 2022
Nasal prevention of SARS-CoV-2 infection by intranasal influenza-based boost vaccination in mouse models
R Zhou, P Wang, YC Wong, H Xu, SY Lau, L Liu, BW Mok, Q Peng, N Liu, KF Woo, S Deng, RC Tam, H Huang, AJ Zhang, D Zhou, B Zhou, CY Chan, Z Du, D Yang, KK Au, KY Yuen, H Chen, Z Chen
EBioMedicine 2022
NETosis and SARS-COV-2 infection related thrombosis: a narrative review
M Behzadifard, M Soleimani
Thrombosis Journal 2022
Adaptive MHC-E restricted tissue-resident NK cells are associated with persistent low antigen load in alveolar macrophages after SARS-CoV-2 infection
Nicolas Huot, Cyril Planchais, Vanessa Contreras, Beatrice Jacquelin, Caroline Petitdemange, Marie Lazzerini, Pierre Rosenbaum, Félix Rey, R Keith Reeves, Roger Le Grand, Hugo Mouquet, Michaela Müller-Trutwin
Research square 2022
The role of antigen-presenting cells in the pathogenesis of COVID-19
R Farzi, P Aghbash, N Eslami, A Azadi, A Shamekh, N Hemmat, T Entezari-Maleki, H Baghi
Pathology, research and practice 2022
Monoclonal antibodies for COVID-19 therapy and SARS-CoV-2 detection
YC Hwang, RM Lu, SC Su, PY Chiang, SH Ko, FY Ke, KH Liang, TY Hsieh, HC Wu
Journal of Biomedical Science 2022
COVID-19 infection: an overview on cytokine storm and related interventions
S Montazersaheb, S Khatibi, M Hejazi, V Tarhriz, A Farjami, F Sorbeni, R Farahzadi, T Ghasemnejad
Virology Journal 2022
The Transient IFN Response and the Delay of Adaptive Immunity Feature the Severity of COVID-19
G Xu, F Qi, H Wang, Y Liu, X Wang, R Zou, J Yuan, X Liao, Y Liu, S Zhang, Z Zhang
Frontiers in immunology 2022
Mechanistic Insights Into the Immune Pathophysiology of COVID-19; An In-Depth Review
A Shafqat, S Shafqat, S Salameh, J Kashir, K Alkattan, A Yaqinuddin
Frontiers in immunology 2022
Neutralizing Antibodies and Antibody-Dependent Enhancement in COVID-19: A Perspective
S Ajmeriya, A Kumar, S Karmakar, S Rana, H Singh
JOURNAL OF THE INDIAN INSTITUTE OF SCIENCE 2022
Relationship between SARS-CoV-2 antibody titer and the severity of COVID-19
J Park, M Cha, H Choi, M Kim, J Chung, K Lee, D Jeong, M Baek, W Kim, Y Lim, S Yoon, S Choi
Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi 2022
The T cell immune response against SARS-CoV-2
P Moss
Nature Immunology 2022
Waning immune responses against SARS-CoV-2 variants of concern among vaccinees in Hong Kong
Q Peng, R Zhou, Y Wang, M Zhao, N Liu, S Li, H Huang, D Yang, K Au, H Wang, K Man, K Yuen, Z Chen
EBioMedicine 2022
COVID-19 Infection in Children and Infants: Current Status on Therapies and Vaccines
G Malcangi, A Inchingolo, A Inchingolo, F Piras, V Settanni, G Garofoli, G Palmieri, S Ceci, A Patano, A Mancini, L Vimercati, D Nemore, A Scardapane, B Rapone, A Semjonova, M DOria, L Macchia, I Bordea, G Migliore, A Scarano, F Lorusso, G Tartaglia, D Giovanniello, L Nucci, N Maggialetti, A Parisi, M Domenico, N Brienza, S Tafuri, P Stefanizzi, L Curatoli, A Corriero, M Contaldo, F Inchingolo, G Dipalma
Children 2022
Immunogenicity and protective efficacy of a recombinant protein subunit vaccine and an inactivated vaccine against SARS-CoV-2 variants in non-human primates.
He Q, Mao Q, Peng X, He Z, Lu S, Zhang J, Gao F, Bian L, An C, Yu W, Yang F, Zhou Y, Yang Y, Li Y, Yuan Y, Yan X, Yang J, Wu X, Huang W, Li C, Wang J, Liang Z, Xu M
Signal Transduction and Targeted Therapy 2022
A Detailed Overview of Immune Escape, Antibody Escape, Partial Vaccine Escape of SARS-CoV-2 and Their Emerging Variants With Escape Mutations.
Chakraborty C, Sharma AR, Bhattacharya M, Lee SS
Frontiers in immunology 2022
IgG targeting distinct seasonal coronavirus- conserved SARS-CoV-2 spike subdomains correlates with differential COVID-19 disease outcomes
Garrido JL, Medina MA, Bravo F, McGee S, Fuentes-Villalobos F, Calvo M, Pinos Y, Bowman JW, Bahl CD, Barria MI, Brachman RA, Alvarez RA
Cell Reports 2022
Vaccine Candidate Against COVID-19 Based on Structurally Modified Plant Virus as an Adjuvant
Kovalenko AO, Ryabchevskaya EM, Evtushenko EA, Manukhova TI, Kondakova OA, Ivanov PA, Arkhipenko MV, Gushchin VA, Nikitin NA, Karpova OV
Frontiers in microbiology 2022
A broadly neutralizing antibody protects Syrian hamsters against SARS-CoV-2 Omicron challenge.
Zhou B, Zhou R, Tang B, Chan JF, Luo M, Peng Q, Yuan S, Liu H, Mok BW, Chen B, Wang P, Poon VK, Chu H, Chan CC, Tsang JO, Chan CC, Au KK, Man HO, Lu L, To KK, Chen H, Yuen KY, Dang S, Chen Z
Nature Communications 2022
Redox Homeostasis and Immune Alterations in Coronavirus Disease-19
Bellanti F, Lo Buglio A, Vendemiale G
Biology 2022
Antibody-dependent enhancement (ADE) of SARS-CoV-2 pseudoviral infection requires FcγRIIB and virus-antibody complex with bivalent interaction
Wang S, Wang J, Yu X, Jiang W, Chen S, Wang R, Wang M, Jiao S, Yang Y, Wang W, Chen H, Chen B, Gu C, Liu C, Wang A, Wang M, Li G, Guo C, Liu D, Zhang J, Zhang M, Wang L, Gui X
2022
COVID-19 Vaccine: Between Myth and Truth
Piccaluga PP, Di Guardo A, Lagni A, Lotti V, Diani E, Navari M, Gibellini D
Human vaccines 2022
Poxvirus MVA Expressing SARS-CoV-2 S Protein Induces Robust Immunity and Protects Rhesus Macaques From SARS-CoV-2
Mooij P, García-Arriaza J, Pérez P, Lázaro-Frías A, Verstrepen BE, Böszörményi KP, Mortier D, Fagrouch Z, Kiemenyi-Kayere G, Niphuis H, Acar RF, Meijer L, Stammes MA, Kondova I, Verschoor EJ, GeurtsvanKessel CH, de Bruin E, Sikkema RS, Luczkowiak J, Delgado R, Montenegro D, Puentes E, Rodríguez E, Bogers WM, Koopman G, Esteban M
Frontiers in immunology 2022
MutCov: A pipeline for evaluating the effect of mutations in spike protein on infectivity and antigenicity of SARS-CoV-2
Zhou W, Xu C, Luo M, Wang P, Xu Z, Xue G, Jin X, Huang Y, Li Y, Nie H, Jiang Q, Anashkina AA
Computers in Biology and Medicine 2022
Th2-Oriented Immune Serum After SARS-CoV-2 Vaccination Does Not Enhance Infection In Vitro
Luan N, Li T, Wang Y, Cao H, Yin X, Lin K, Liu C
Frontiers in immunology 2022
Vaccines for COVID-19: A Systematic Review of Immunogenicity, Current Development, and Future Prospects
Zhang Z, Shen Q, Chang H
Frontiers in immunology 2022
A Case Study to Dissect Immunity to SARS-CoV-2 in a Neonate Nonhuman Primate Model
Fovet CM, Pimienta C, Galhaut M, Relouzat F, Nunez N, Cavarelli M, Sconosciuti Q, Dhooge N, Marzinotto I, Lampasona V, Tolazzi M, Scarlatti G, Ho Tsong Fang R, Naninck T, Dereuddre-Bosquet N, Van Wassenhove J, Gallouët AS, Maisonnasse P, Le Grand R, Menu E, Seddiki N
Frontiers in immunology 2022
Is COVID-19 really a geriatric syndrome?
Akbarzadeh MA, Hosseini MS
Ageing Research Reviews 2022
COVID-19 associated pediatric vasculitis: A systematic review and detailed analysis of the pathogenesis
Batu ED, Sener S, Ozen S
Seminars in Arthritis and Rheumatism 2022
A Review on Immunological Responses to SARS-CoV-2 and Various COVID-19 Vaccine Regimens
Upreti S, Samant M
Pharmaceutical Research 2022
Protection of hamsters challenged with SARS-CoV-2 after two doses of MVC-COV1901 vaccine followed by a single intranasal booster with nanoemulsion adjuvanted S-2P vaccine
Lin YJ, Lin MY, Chuang YS, Liu LT, Kuo TY, Chen C, Ganesan S, Fattom A, Bitko V, Lien CE
Scientific Reports 2022
Longitudinal immune profiling reveals dominant epitopes mediating long-term humoral immunity in COVID-19-convalescent individuals.
Li M, Liu J, Lu R, Zhang Y, Du M, Xing M, Wu Z, Kong X, Zhu Y, Zhou X, Hu L, Zhang C, Zhou D, Jin X
Journal of Allergy and Clinical Immunology 2022
Interleukin 6 and Its Correlation with COVID-19 in Terms of Outcomes in an Intensive Care Unit of a Rural Hospital:A Cross-sectional Study.
Talwar D, Kumar S, Acharya S, Raisinghani N, Madaan S, Hulkoti V, Akhilesh A, Khanna S, Shah D, Nimkar S
Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine 2022
Predicted impact of the viral mutational landscape on the cytotoxic response against SARS-CoV-2.
Foix A, López D, Díez-Fuertes F, McConnell MJ, Martín-Galiano AJ
PLoS computational biology 2022
A Review of Coronaviruses Associated With Kawasaki Disease: Possible Implications for Pathogenesis of the Multisystem Inflammatory Syndrome Associated With COVID-19.
Shahbaz FF, Martins RS, Umair A, Ukrani RD, Jabeen K, Sohail MR, Khan E
Clinical Medicine Insights Pediatrics 2022
Anti-SARS-CoV-2 IgG and IgA antibodies in COVID-19 convalescent plasma do not enhance viral infection.
Clark NM, Janaka SK, Hartman W, Stramer S, Goodhue E, Weiss J, Evans DT, Connor JP
PloS one 2022
Vaccine-Associated Enhanced Disease and Pathogenic Human Coronaviruses.
Gartlan C, Tipton T, Salguero FJ, Sattentau Q, Gorringe A, Carroll MW
Frontiers in immunology 2022
Long-Term Immunity and Antibody Response: Challenges for Developing Efficient COVID-19 Vaccines.
Sepand MR, Bigdelou B, Ho JQ, Sharaf M, Lannigan AJ, Sullivan IM, da Silva AP, Barrett LO, McGoldrick S, Lnu Y, Lynch SE, Boisclair JM, Barnard-Pratt DD, Zanganeh S
2022
COVID-19 and plasma cells: Is there long-lived protection?
Nguyen DC, Lamothe PA, Woodruff MC, Saini AS, Faliti CE, Sanz I, Lee FE
Immunological Reviews 2022
A modified porous silicon microparticle potentiates protective systemic and mucosal immunity for SARS-CoV-2 subunit vaccine
Adam A, Shi Q, Wang B, Zou J, Mai J, Osman SR, Wu W, Xie X, Aguilar PV, Bao X, Shi PY, Shen H, Wang T
Translational Research 2022
Multisystem inflammatory syndrome in neonates (MIS-N) associated with SARS-CoV2 infection: a case series
More K, Aiyer S, Goti A, Parikh M, Sheikh S, Patel G, Kallem V, Soni R, Kumar P
European Journal of Pediatrics 2022
Anti-SARS-CoV-2 Titers Predict the Severity of COVID-19
Kritikos A, Gabellon S, Pagani JL, Monti M, Bochud PY, Manuel O, Coste A, Greub G, Perreau M, Pantaleo G, Croxatto A, Lamoth F
Viruses 2022
Non-neutralizing antibodies: Deleterious or propitious during SARS-CoV-2 infection?
Zanella I, Degli Antoni M, Marchese V, Castelli F, Quiros-Roldan E
International Immunopharmacology 2022
Advances in nanotechnology application in biosafety materials: A crucial response to COVID-19 pandemic
Morajkar RV, Kumar AS, Kunkalekar RK, Vernekar AA
2022
Alveolar macrophages: Achilles’ heel of SARS-CoV-2 infection
Wang Z, Li S, Huang B
Signal Transduction and Targeted Therapy 2022
Post-COVID-19 HSV encephalitis: a review.
Gupta S, Dutta A, Chakraborty U, Kumar R, Das D, Ray BK
QJM : monthly journal of the Association of Physicians 2022
Antibody-mediated immunity to SARS-CoV-2 spike
Errico JM, Adams LJ, Fremont DH
Advances in immunology 2022
Vaccine-associated enhanced disease in humans and animal models: Lessons and challenges for vaccine development
Bigay J, Le Grand R, Martinon F, Maisonnasse P
Frontiers in microbiology 2022
Host and microbiome features of secondary infections in lethal covid-19.
Zacharias M, Kashofer K, Wurm P, Regitnig P, Schütte M, Neger M, Ehmann S, Marsh LM, Kwapiszewska G, Loibner M, Birnhuber A, Leitner E, Thüringer A, Winter E, Sauer S, Pollheimer MJ, Vagena FR, Lackner C, Jelusic B, Ogilvie L, Durdevic M, Timmermann B, Lehrach H, Zatloukal K, Gorkiewicz G
iScience 2022
Heterologous immunization with adenovirus vectored and inactivated vaccines effectively protects against SARS-CoV-2 variants in mice and macaques
He Q, Mao Q, Zhang J, Gao F, Bai Y, Cui B, Liu J, An C, Wang Q, Yan X, Yang J, Song L, Song Z, Liu D, Yuan Y, Sun J, Zhao J, Bian L, Wu X, Huang W, Li C, Wang J, Liang Z, Xu M
Frontiers in immunology 2022
Anti-Spike Antibody Response to Natural Infection with SARS-CoV-2 and Its Activity against Emerging Variants
Chen CP, Huang KY, Shih SR, Lin YC, Cheng CY, Huang YC, Lin TY, Cheng SH
Microbiology spectrum 2022
An ACE2-IgG4 Fc Fusion Protein Demonstrates Strong Binding to All Tested SARS-CoV-2 Variants and Reduced Lung Inflammation in Animal Models of SARS-CoV-2 and Influenza
Merigeon EY, Yang D, Ihms EA, Bassit LC, Fitzpatrick EA, Jonsson CB, Schinazi RF, Block DS, Olsen HS
Pathogens and Immunity 2022
The role of B cells in COVID-19 infection and vaccination
Chen S, Guan F, Candotti F, Benlagha K, Camara NO, Herrada AA, James LK, Lei J, Miller H, Kubo M, Ning Q, Liu C
Frontiers in immunology 2022
Focus on long non-coding RNA MALAT1: Insights into acute and chronic lung diseases
Lai X, Zhong J, Zhang A, Zhang B, Zhu T, Liao R
Frontiers in Genetics 2022
Vaccines platforms and COVID-19: what you need to know
Acosta-Coley I, Cervantes-Ceballos L, Tejeda-Benítez L, Sierra-Márquez L, Cabarcas-Montalvo M, García-Espiñeira M, Coronell-Rodríguez W, Arroyo-Salgado B
Tropical Diseases, Travel Medicine and Vaccines 2022
Broad‐spectrum antiviral activity of Spatholobus suberectus Dunn against SARS‐CoV‐2, SARS‐CoV‐1, H5N1, and other enveloped viruses
Liu Q, Kwan K, Cao T, Yan B, Ganesan K, Jia L, Zhang F, Lim C, Wu Y, Feng Y, Chen Z, Liu L, Chen J
Phytotherapy Research 2022
SARS‐CoV‐2 vaccines: A double‐edged sword throughout rapid evolution of COVID‐19
Zolfaghari MA, Ghadiri Moghaddam F, Rajput S, Karimi A, Naghi Vishteh M, Mahmoodpoor A, Dolati S, Yousefi M
Cell biology international 2022
Highly pathogenic coronaviruses and the kidney
Wang F, Suo XG, Wang C, Wang JN, He XY, Wang FC, Jin J, Wen JG, Ni WJ, Shen BX, Meng XM
Biomedicine & Pharmacotherapy 2022
Naturally occurring spike mutations influence the infectivity and immunogenicity of SARS-CoV-2
Peng Q, Zhou R, Liu N, Wang H, Xu H, Zhao M, Yang D, Au KK, Huang H, Liu L, Chen Z
Cellular and Molecular Immunology 2022
SARS-CoV-2 and HIV-1: So Different yet so Alike. Immune Response at the Cellular and Molecular Level.
Demoliou C, Papaneophytou C, Nicolaidou V
International journal of medical sciences 2022
Intranasal nanoemulsion adjuvanted S-2P vaccine demonstrates protection in hamsters and induces systemic, cell-mediated and mucosal immunity in mice.
Ganesan S, Acosta H, Brigolin C, Orange K, Trabbic K, Chen C, Lien CE, Lin YJ, Lin MY, Chuang YS, Fattom A, Bitko V
PloS one 2022
Non-Neutralizing Epitopes Shade Neutralizing Epitopes against Omicron in a Multiple Epitope-Based Vaccine
Gong HR, Hu YF, Li X, Yau T, Zhang BZ, Huang JD
ACS Infectious Diseases 2022
Conserved longitudinal alterations of anti-S-protein IgG subclasses in disease progression in initial ancestral Wuhan and vaccine breakthrough Delta infections.
Goh YS, Fong SW, Hor PX, Amrun SN, Lee CY, Young BE, Chia PY, Tambyah PA, Kalimuddin S, Pada S, Tan SY, Sun LJ, Chen MI, Leo YS, Lye DC, Ng LFP, Renia L
Frontiers in microbiology 2022
SARS-CoV-2 infection of phagocytic immune cells and COVID-19 pathology: Antibody-dependent as well as independent cell entry.
Matveeva O, Nechipurenko Y, Lagutkin D, Yegorov YE, Kzhyshkowska J
Frontiers in immunology 2022
The frequency and seasonal distribution of viral infection in patients with community-acquired pneumonia and its impact on the prognosis
Kim KJ, Kim DH
2022
Impaired VEGF-A-Mediated Neurovascular Crosstalk Induced by SARS-CoV-2 Spike Protein: A Potential Hypothesis Explaining Long COVID-19 Symptoms and COVID-19 Vaccine Side Effects?
Talotta R
Microorganisms 2022
Development of an ELISA Assay for the Determination of SARS-CoV-2 Protein Subunit Vaccine Antigen Content
Han L, An C, Liu D, Wang Z, Bian L, He Q, Liu J, Wang Q, Liu M, Mao Q, Hang T, Wang A, Gao F, Tan D, Liang Z
Viruses 2022
Dissecting strategies to tune the therapeutic potential of SARS-CoV-2-specific monoclonal antibody CR3022
Caroline Atyeo, Matthew D. Slein, Stephanie Fischinger, John S. Burke, Alexandra Schafer, Sarah R. Leist, Natalia A. Kuzmina, Chad E. Mire, Anna Honko, Rebecca I. Johnson, Nadia Storm, Matthew J. Bernett, Pei Tong, Teng Zuo, Junrui Lin, Adam Zuiani, Caitlyn H. Linde, Todd J. Suscovich, Duane R. Wesemann, Anthony Griffiths, John R. Desjarlais, Boris D. Julg, Jaap Goudsmit, Alexander Bukreyev, Ralph Baric, Galit Alter
JCI Insight 2021
Natural Mucosal Barriers and COVID-19 in Children
Carl A. Pierce, Sharlene Sy, Benjamin Galen, Doctor Y Goldstein, Erika P Orner, Marla J. Keller, Kevan C Herold, Betsy Herold
JCI Insight 2021
Intradermal delivery of a synthetic DNA vaccine protects macaques from Middle East respiratory syndrome coronavirus
Ami Patel, Emma L. Reuschel, Ziyang Xu, Faraz I. Zaidi, Kevin Y. Kim, Dana Scott, Janess Mendoza, Stephanie Ramos, Regina Stoltz, Friederike Feldmann, Atsushi Okumura, Kimberly Meade-White, Elaine Haddock, Tina Thomas, Rebecca Rosenke, Jamie Lovaglio, Patrick W Hanley, Greg Saturday, Kar Muthumani, Heinz Feldmann, Laurent Humeau, Kate Broderick, David B Weiner
JCI Insight 2021
Serological analysis reveals an imbalanced IgG subclass composition associated with COVID-19 disease severity
JL Yates, DJ Ehrbar, DT Hunt, RC Girardin, AP Dupuis, AF Payne, M Sowizral, S Varney, KE Kulas, VL Demarest, KM Howard, K Carson, M Hales, M Ejemel, Q Li, Y Wang, R Peredo-Wende, A Ramani, G Singh, K Strle, NJ Mantis, KA McDonough, WT Lee
Reproduction 2021
High neutralizing potency of swine glyco‐humanized polyclonal antibodies against SARS‐CoV‐2
B Vanhove, O Duvaux, J Rousse, PJ Royer, G Evanno, C Ciron, E Lheriteau, L Vacher, N Gervois, R Oger, Y Jacques, S Conchon, A Salama, R Duchi, I Lagutina, A Perota, P Delahaut, M Ledure, M Paulus, RT So, CK Mok, R Bruzzone, M Bouillet, S Brouard, E Cozzi, C Galli, D Blanchard, JM Bach, JP Soulillou
European Journal of Immunology 2021
Combining Antivirals and Immunomodulators to Fight COVID-19
V Feuillet, B Canard, A Trautmann
Trends in Immunology 2021
Physiological and Pathological Inflammation Induced by Antibodies and Pentraxins
CE Geyer, L Mes, M Newling, J den Dunnen, W Hoepel
Cells 2021
Microglial Implications in SARS-CoV-2 Infection and COVID-19: Lessons From Viral RNA Neurotropism and Possible Relevance to Parkinson’s Disease
IO Awogbindin, B Ben-Azu, BA Olusola, ET Akinluyi, PA Adeniyi, TD Paolo, MÈ Tremblay
Frontiers in cellular neuroscience 2021
COVID-19 Infection in Children, Infants and Pregnant Subjects: An Overview of Recent Insights and Therapies
G Malcangi, AD Inchingolo, AM Inchingolo, L Santacroce, G Marinelli, A Mancini, L Vimercati, ME Maggiore, MT DOria, D Hazballa, IR Bordea, E Xhajanka, A Scarano, M Farronato, GM Tartaglia, D Giovanniello, L Nucci, R Serpico, G Sammartino, L Capozzi, A Parisi, MD Domenico, F Lorusso, M Contaldo, F Inchingolo, G Dipalma
Microorganisms 2021
Pathogenesis of Respiratory Viral and Fungal Coinfections
F Salazar, E Bignell, GD Brown, PC Cook, A Warris
Clinical microbiology reviews 2021
Vectored Immunotherapeutics for Infectious Diseases: Can rAAVs Be The Game Changers for Fighting Transmissible Pathogens?
W Zhan, M Muhuri, PW Tai, G Gao
Frontiers in immunology 2021
An overview of some potential immunotherapeutic options against COVID-19
M Bayat, Y Asemani, MR Mohammadi, M Sanaei, M Namvarpour, R Eftekhari
International Immunopharmacology 2021
Immunomodulatory Effects of Azithromycin Revisited: Potential Applications to COVID-19
VJ Venditto, D Haydar, A Abdel-Latif, JC Gensel, MI Anstead, MG Pitts, J Creameans, TJ Kopper, C Peng, DJ Feola
Frontiers in immunology 2021
COVID-19: Immunology, Immunopathogenesis and Potential Therapies
A Bhardwaj, L Sapra, C Saini, Z Azam, PK Mishra, B Verma, GC Mishra, RK Srivastava
International Reviews of Immunology 2021
Immune dysregulation and immunopathology induced by SARS-CoV-2 and related coronaviruses — are we our own worst enemy?
LY Wong, S Perlman
Nature Reviews Immunology 2021
High titers and low fucosylation of early human anti–SARS-CoV-2 IgG promote inflammation by alveolar macrophages
W Hoepel, HJ Chen, CE Geyer, S Allahverdiyeva, XD Manz, SW de Taeye, J Aman, L Mes, M Steenhuis, GR Griffith, PI Bonta, PJ Brouwer, TG Caniels, K van der Straten, K Golebski, RE Jonkers, MD Larsen, F Linty, J Nouta, CP van Roomen, FE van Baarle, CM van Drunen, G Wolbink, AP Vlaar, GJ de Bree, RW Sanders, L Willemsen, AE Neele, D van de Beek, T Rispens, M Wuhrer, HJ Bogaard, MJ van Gils, G Vidarsson, M de Winther, J den Dunnen
Science Translational Medicine 2021
Afucosylated IgG characterizes enveloped viral responses and correlates with COVID-19 severity
MD Larsen, EL de Graaf, ME Sonneveld, HR Plomp, J Nouta, W Hoepel, HJ Chen, F Linty, R Visser, M Brinkhaus, T Šuštić, SW de Taeye, AE Bentlage, S Toivonen, CA Koeleman, S Sainio, NA Kootstra, PJ Brouwer, CE Geyer, NI Derksen, G Wolbink, M de Winther, RW Sanders, MJ van Gils, S de Bruin, AP Vlaar, T Rispens, J den Dunnen, HL Zaaijer, M Wuhrer, CE van der Schoot, G Vidarsson, M van Agtmael, AG Algera, F van Baarle, D Bax, D van de Beek, M Beudel, HJ Bogaard, PI Bonta, M Bomers, L Bos, M Botta, G de Bree, MC Brouwer, J Brabander, S de Bruin, M Bugiani, E Bulle, O Chouchane, A Cloherty, P Elbers, L Fleuren, S Geerlings, B Geerts, T Geijtenbeek, A Girbes, B Goorhuis, MP Grobusch, F Hafkamp, L Hagens, J Hamann, V Harris, R Hemke, SM Hermans, L Heunks, MW Hollmann, J Horn, JW Hovius, M de Jong, R Koning, N van Mourik, J Nellen, EJ Nossent, F Paulus, E Peters, T van der Poll, B Preckel, JM Prins, J Raasveld, T Rijnders, M Schinkel, M Schultz, AR Schuurmans, K Sigaloff, M Smit, CS Stijnis, W Stilma, C Teunissen, P Thoral, A Tsonas, M van der Valk, D Veelo, AP Vlaar, H de Vries, M van Vugt, WJ Wiersinga, D Wouters, AH Zwinderman
Science 2021
Immunomodulation: Immunoglobulin Preparations Suppress Hyperinflammation in a COVID-19 Model via FcγRIIA and FcαRI
F Bohländer, D Riehl, S Weißmüller, M Gutscher, J Schüttrumpf, S Faust
Frontiers in immunology 2021
Deregulated cellular circuits driving immunoglobulins and complement consumption associate with the severity of COVID‐19 patients
A MarcosJiménez, S SánchezAlonso, A AlcarazSerna, L Esparcia, C LópezSanz, M SampedroNúñez, T MateuAlbero, I SánchezCerrillo, P MartínezFleta, L Gabrie, LC Guerola, JM RodríguezFrade, JM Casasnovas, HT Reyburn, M ValésGómez, M LópezTrascasa, E MartínGayo, MJ Calzada, S Castañeda, H Fuente, I GonzálezÁlvaro, F SánchezMadrid, C MuñozCalleja, A Alfranca
European Journal of Immunology 2021
Cellular and Humoral Immune Responses in Covid-19 and Immunotherapeutic Approaches
A Hasan, E Al-Ozairi, Z Al-Baqsumi, R Ahmad, F Al-Mulla
ImmunoTargets and Therapy 2021
Vaccine formulations in clinical development for the prevention of severe acute respiratory syndrome coronavirus 2 infection
CJ Batty, MT Heise, EM Bachelder, KM Ainslie
Advanced Drug Delivery Reviews 2021
Requirement of Fc-Fc Gamma Receptor Interaction for Antibody-Based Protection against Emerging Virus Infections
SP Keeler, JM Fox
Viruses 2021
The Current Status and Challenges in the Development of Vaccines and Drugs against Severe Acute Respiratory Syndrome-Corona Virus-2 (SARS-CoV-2)
N Beeraka, S Tulimilli, M Karnik, S Sadhu, R Pragada, G Aliev, S Madhunapantula, J Lu
BioMed Research International 2021
Complement Anaphylatoxins and Inflammatory Cytokines as Prognostic Markers for COVID-19 Severity and In-Hospital Mortality
B Alosaimi, A Mubarak, ME Hamed, AZ Almutairi, AA Alrashed, A AlJuryyan, M Enani, FQ Alenzi, W Alturaiki
Frontiers in immunology 2021
Systems serology detects functionally distinct coronavirus antibody features in children and elderly
KJ Selva, CE van de Sandt, MM Lemke, CY Lee, SK Shoffner, BY Chua, SK Davis, TH Nguyen, LC Rowntree, L Hensen, M Koutsakos, CY Wong, F Mordant, DC Jackson, KL Flanagan, J Crowe, S Tosif, MR Neeland, P Sutton, PV Licciardi, NW Crawford, AC Cheng, DL Doolan, F Amanat, F Krammer, K Chappell, N Modhiran, D Watterson, P Young, WS Lee, BD Wines, PM Hogarth, R Esterbauer, HG Kelly, HX Tan, JA Juno, AK Wheatley, SJ Kent, KB Arnold, K Kedzierska, AW Chung
Nature Communications 2021
The immune response to SARS-CoV-2 and COVID-19 immunopathology – Current perspectives
JL Boechat, I Chora, A Morais, L Delgado
2021
Spontaneous apoptosis of cells in therapeutic stem cell preparation exert immunomodulatory effects through release of phosphatidylserine
X He, W Hong, J Yang, H Lei, T Lu, C He, Z Bi, X Pan, Y Liu, L Dai, W Wang, C Huang, H Deng, X Wei
Signal Transduction and Targeted Therapy 2021
Seroprevalence of Antibodies against SARS-CoV-2 in Children with Juvenile Idiopathic Arthritis a Case-Control Study
V Opoka-Winiarska, E Grywalska, I Korona-Glowniak, K Matuska, A Malm, J Roliński
Journal of Clinical Medicine 2021
Immune dysregulation and system pathology in COVID-19
M Jamal, HI Bangash, M Habiba, Y Lei, T Xie, J Sun, Z Wei, Z Hong, L Shao, Q Zhang
Virulence 2021
Circuits between infected macrophages and T cells in SARS-CoV-2 pneumonia
RA Grant, L Morales-Nebreda, NS Markov, S Swaminathan, M Querrey, ER Guzman, DA Abbott, HK Donnelly, A Donayre, IA Goldberg, ZM Klug, N Borkowski, Z Lu, H Kihshen, Y Politanska, L Sichizya, M Kang, A Shilatifard, C Qi, JW Lomasney, AC Argento, JM Kruser, ES Malsin, CO Pickens, SB Smith, JM Walter, AE Pawlowski, D Schneider, P Nannapaneni, H Abdala-Valencia, A Bharat, CJ Gottardi, GR Budinger, AV Misharin, BD Singer, RG Wunderink
Nature 2021
Immunological Approaches to the Treatment of Novel Coronavirus Infection (Review)
NA Lyubavina, SG Saltsev, NV Menkov, LV Tyurikova, SS Plastinina, ML Shonia, AA Tulichev, MY Milyutina, EV Makarova
2021
SARS-CoV-2: vaccines in the pandemic era
DD Li, QH Li
Military Medical Research 2021
A look-back at convalescent plasma to treat COVID-19
O Garraud, K Lacombe, P Tiberghien
Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis 2021
SARS-CoV-2 neutralizing human recombinant antibodies selected from pre-pandemic healthy donors binding at RBD-ACE2 interface
F Bertoglio, D Meier, N Langreder, S Steinke, U Rand, L Simonelli, PA Heine, R Ballmann, KT Schneider, KD Roth, M Ruschig, P Riese, K Eschke, Y Kim, D Schäckermann, M Pedotti, P Kuhn, S Zock-Emmenthal, J Wöhrle, N Kilb, T Herz, M Becker, M Grasshoff, EV Wenzel, G Russo, A Kröger, L Brunotte, S Ludwig, V Fühner, SD Krämer, S Dübel, L Varani, G Roth, L Čičin-Šain, M Schubert, M Hust
Nature Communications 2021
Bridging animal and clinical research during SARS-CoV-2 pandemic: A new-old challenge
MS Winkler, T Skirecki, FM Brunkhorst, S Cajander, JM Cavaillon, R Ferrer, SB Flohé, A García-Salido, EJ Giamarellos-Bourboulis, M Girardis, M Kox, G Lachmann, I Martin-Loeches, MG Netea, T Spinetti, JC Schefold, A Torres, F Uhle, F Venet, S Weis, A Scherag, I Rubio, MF Osuchowski
EBioMedicine 2021
Characterization of an attenuated SARS-CoV-2 variant with a deletion at the S1/S2 junction of the spike protein
P Wang, SY Lau, S Deng, P Chen, BW Mok, AJ Zhang, AC Lee, KH Chan, RC Tam, H Xu, R Zhou, W Song, L Liu, KK To, JF Chan, Z Chen, KY Yuen, H Chen
Nature Communications 2021
Endocytosis and Transcytosis of SARS-CoV-2 Across the Intestinal Epithelium and Other Tissue Barriers
E Knyazev, S Nersisyan, A Tonevitsky
Frontiers in immunology 2021
COVID-19: inflammatory responses, structure-based drug design and potential therapeutics
N Tripathi, N Tripathi, MK Goshisht
Molecular Diversity 2021
Serum β2-microglobulin levels in Coronavirus disease 2019 (Covid-19): Another prognosticator of disease severity?
W Conca, M Alabdely, F Albaiz, MW Foster, M Alamri, M Alkaff, F Al-Mohanna, N Nagelkerke, RS Almaghrabi, C Lazzeri
PloS one 2021
The conundrum of current anti-SARS-CoV-2 vaccines
M Federico
Cytokine & Growth Factor Reviews 2021
Monocytes and Macrophages in COVID-19
R Knoll, JL Schultze, J Schulte-Schrepping
Frontiers in immunology 2021
Highly active engineered IgG3 antibodies against SARS-CoV-2
S Kallolimath, L Sun, R Palt, K Stiasny, P Mayrhofer, C Gruber, B Kogelmann, Q Chen, H Steinkellner
Proceedings of the National Academy of Sciences 2021
COVID-19 and HIV-Associated Immune Reconstitution Inflammatory Syndrome: Emergence of Pathogen-Specific Immune Responses Adding Fuel to the Fire
N Seddiki, M French
Frontiers in immunology 2021
Structure of SARS-CoV-2 Spike Glycoprotein for Therapeutic and Preventive Target
J Hong, H Jhun, YO Choi, AS Taitt, S Bae, Y Lee, C Song, SC Yeom, S Kim
Immune Network 2021
A vaccine inducing solely cytotoxic T lymphocytes fully prevents Zika virus infection and fetal damage
F Gambino, W Tai, D Voronin, Y Zhang, X Zhang, J Shi, X Wang, N Wang, L Du, L Qiao
Cell Reports 2021
Immunology, immunopathogenesis and immunotherapeutics of COVID-19; an overview
LM Khosroshahi, M Rokni, T Mokhtari, F Noorbakhsh
International Immunopharmacology 2021
Putative Role of Vitamin D for COVID-19 Vaccination
SK Chiu, KW Tsai, CC Wu, CM Zheng, CH Yang, WC Hu, YC Hou, KC Lu, YC Chao
International journal of molecular sciences 2021
A review of COVID-19 convalescent plasma use in COVID-19 with focus on proof of efficacy
PK Devarasetti, L Rajasekhar, R Baisya, KS Sreejitha, YK Vardhan
Immunologic Research 2021
Untapping host-targeting cross-protective efficacy of anticoagulants against SARS-CoV-2
BF Niemeyer, KH Benam
Pharmacology & Therapeutics 2021
Humoral immune responses and neutralizing antibodies against SARS-CoV-2; implications in pathogenesis and protective immunity
J Carrillo, N Izquierdo-Useros, C Ávila-Nieto, E Pradenas, B Clotet, J Blanco
Biochemical and Biophysical Research Communications 2021
Personalized therapy: can it tame the COVID-19 monster?
M Arish, F Naz
Personalized Medicine 2021
Monocytes and macrophages in COVID-19: Friends and foes
S Meidaninikjeh, N Sabouni, HZ Marzouni, S Bengar, A Khalili, R Jafari
Life Sciences 2021
Distinctive features of SARS-CoV-2-specific T cells predict recovery from severe COVID-19
J Neidleman, X Luo, AF George, M McGregor, J Yang, C Yun, V Murray, G Gill, WC Greene, J Vasquez, SA Lee, E Ghosn, KL Lynch, NR Roan
Cell Reports 2021
Reaktionsmuster der lokoregionären Lymphknoten im Abflussgebiet von COVID-19-Lungen
JD Haslbauer, MS Matter, AK Stalder, A Tzankov
Der Pathologe 2021
Use of convalescent serum reduces severity of COVID-19 in nonhuman primates
RW Cross, AN Prasad, V Borisevich, C Woolsey, KN Agans, DJ Deer, NS Dobias, JB Geisbert, KA Fenton, TW Geisbert
Cell Reports 2021
Integrative overview of antibodies against SARS-CoV-2 and their possible applications in COVID-19 prophylaxis and treatment
NA Valdez-Cruz, E García-Hernández, C Espitia, L Cobos-Marín, C Altamirano, CG Bando-Campos, LF Cofas-Vargas, EW Coronado-Aceves, RA González-Hernández, P Hernández-Peralta, D Juárez-López, PA Ortega-Portilla, S Restrepo-Pineda, P Zelada-Cordero, MA Trujillo-Roldán
Microbial cell factories 2021
Vaccine-Associated Enhanced Viral Disease: Implications for Viral Vaccine Development
SB Halstead
BioDrugs 2021
Vaccine-associated enhanced disease: Case definition and guidelines for data collection, analysis, and presentation of immunization safety data
FM Munoz, JP Cramer, CL Dekker, MZ Dudley, BS Graham, M Gurwith, B Law, S Perlman, FP Polack, JM Spergel, EV Braeckel, BJ Ward, AM Didierlaurent, PH Lambert
Vaccine 2021
Histomorphological patterns of regional lymph nodes in COVID-19 lungs
JD Haslbauer, MS Matter, AK Stalder, A Tzankov
Der Pathologe 2021
A Fc engineering approach to define functional humoral correlates of immunity against Ebola virus
BM Gunn, R Lu, MD Slein, PA Ilinykh, K Huang, C Atyeo, SL Schendel, J Kim, C Cain, V Roy, TJ Suscovich, A Takada, PJ Halfmann, Y Kawaoka, MG Pauthner, M Momoh, A Goba, L Kanneh, KG Andersen, JS Schieffelin, D Grant, RF Garry, EO Saphire, A Bukreyev, G Alter
Immunity 2021
Cross-reactive antibody against human coronavirus OC43 spike protein correlates with disease severity in COVID-19 patients: a retrospective study
L Guo, Y Wang, L Kang, Y Hu, L Wang, J Zhong, H Chen, L Ren, X Gu, G Wang, C Wang, X Dong, C Wu, L Han, Y Wang, G Fan, X Zou, H Li, J Xu, Q Jin, B Cao, J Wang
Emerging Microbes & Infections 2021
Prevention and treatment of COVID-19: Focus on interferons, chloroquine/hydroxychloroquine, azithromycin, and vaccine
BM Bakadia, F He, T Souho, L Lamboni, MW Ullah, BO Boni, AA Ahmed, BM Mukole, G Yang
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2021
Recombinant Antigens Based on Non-Glycosylated Regions from RBD SARS-CoV-2 as Potential Vaccine Candidates against COVID-19
L Núñez-Muñoz, G Marcelino-Pérez, B Calderón-Pérez, M Pérez-Saldívar, K Acosta-Virgen, H González-Conchillos, B Vargas-Hernández, A Olivares-Martínez, R Ruiz-Medrano, D Roa-Velázquez, E Morales-Ríos, J Ramos-Flores, G Torres-Franco, D Peláez-González, J Fernández-Hernández, M Espinosa-Cantellano, D Tapia-Sidas, JA Ramírez-Pool, A Padilla-Viveros, B Xoconostle-Cázares
Human vaccines 2021
Fundamental and Advanced Therapies, Vaccine Development against SARS-CoV-2
N Hudakova, S Hricikova, A Kulkarni, M Bhide, E Kontsekova, D Cizkova
Pathogens 2021
Two Different Antibody-Dependent Enhancement (ADE) Risks for SARS-CoV-2 Antibodies
DO Ricke
Frontiers in immunology 2021
Antibody landscape against SARS-CoV-2 reveals significant differences between non-structural/accessory and structural proteins
Y Li, Z Xu, Q Lei, D Lai, H Hou, H Jiang, Y Zheng, X Wang, J Wu, M Ma, B Zhang, H Chen, C Yu, J Xue, H Zhang, H Qi, S Guo, Y Zhang, X Lin, Z Yao, H Sheng, Z Sun, F Wang, X Fan, S Tao
Cell Reports 2021
COVID-19 in Immunosuppressed Children
E Nicastro, L Verdoni, LR Bettini, G Zuin, A Balduzzi, G Montini, A Biondi, L D'Antiga
Frontiers in Pediatrics 2021
Convalescent plasma for adults with acute COVID-19 respiratory illness (CONCOR-1): study protocol for an international, multicentre, randomized, open-label trial
P Bégin, J Callum, NM Heddle, R Cook, MP Zeller, A Tinmouth, DA Fergusson, MM Cushing, MJ Glesby, M Chassé, DV Devine, N Robitalle, R Bazin, N Shehata, A Finzi, A McGeer, DC Scales, L Schwartz, AF Turgeon, R Zarychanski, N Daneman, R Carl, L Amorim, C Gabe, M Ellis, BS Sachais, KC Loftsgard, E Jamula, J Carruthers, J Duncan, K Lucier, N Li, Y Liu, C Armali, A Kron, D Modi, MC Auclair, S Cerro, M Avram, DM Arnold
Trials 2021
Understanding the Host Innate Immune Responses against SARS-CoV-2 Infection and COVID-19 Pathogenesis
YW Kang, S Park, KJ Lee, D Moon, YM Kim, SW Lee
Immune Network 2021
AI Aided Design of Epitope-Based Vaccine for the Induction of Cellular Immune Responses Against SARS-CoV-2
G Mazzocco, I Niemiec, A Myronov, P Skoczylas, J Kaczmarczyk, A Sanecka-Duin, K Gruba, P Król, M Drwal, M Szczepanik, K Pyrc, P Stȩpniak
Frontiers in Genetics 2021
Humoral Immunity against SARS-CoV-2 and the Impact on COVID-19 Pathogenesis
E Lee, JE Oh
Molecules and Cells 2021
Enhancement versus neutralization by SARS-CoV-2 antibodies from a convalescent donor associates with distinct epitopes on the RBD
Y Zhou, Z Liu, S Li, W Xu, Q Zhang, IT Silva, C Li, Y Wu, Q Jiang, Z Liu, Q Wang, Y Guo, J Wu, C Gu, X Cai, D Qu, CT Mayer, X Wang, S Jiang, T Ying, Z Yuan, Y Xie, Y Wen, L Lu, Q Wang
Cell Reports 2021
Disease-modifying therapies and SARS-CoV-2 vaccination in multiple sclerosis: an expert consensus
D Centonze, MA Rocca, C Gasperini, L Kappos, HP Hartung, M Magyari, C Oreja-Guevara, M Trojano, H Wiendl, M Filippi
Journal of Neurology 2021
COVID-19 Immunobiology: Lessons Learned, New Questions Arise
A Kaklamanos, K Belogiannis, P Skendros, VG Gorgoulis, PG Vlachoyiannopoulos, AG Tzioufas
Frontiers in immunology 2021
Targeting of the CD80/86 proinflammatory axis as a therapeutic strategy to prevent severe COVID-19
A Julià, I Bonafonte-Pardàs, A Gómez, M López-Lasanta, M López-Corbeto, SH Martínez-Mateu, J Lladós, I Rodríguez-Nunez, RM Myers, S Marsal
Scientific Reports 2021
Severe Clinical Worsening in COVID-19 and Potential Mechanisms of Immune-Enhanced Disease
JP Hussman
Frontiers in Medicine 2021
Impact of Treatment Regimens on Antibody Response to the SARS-CoV-2 Coronavirus
Y Shang, T Liu, J Li, NM Kaweme, X Wang, F Zhou
Frontiers in immunology 2021
Molecular mechanism of interaction between SARS-CoV-2 and host cells and interventional therapy
Q Zhang, R Xiang, S Huo, Y Zhou, S Jiang, Q Wang, F Yu
Signal Transduction and Targeted Therapy 2021
Recovery scenario and immunity in COVID-19 disease: A new strategy to predict the potential of reinfection
Z Khoshkam, Y Aftabi, P Stenvinkel, BP Lawrence, MH Rezaei, G Ichihara, S Fereidouni
Journal of Advanced Research 2021
Potential impact of individual exposure histories to endemic human coronaviruses on age-dependent severity of COVID-19
F Pinotti, PS Wikramaratna, U Obolski, RS Paton, DS Damineli, LC Alcantara, M Giovanetti, S Gupta, J Lourenço
BMC Medicine 2021
Development of a high‐sensitivity ELISA detecting IgG, IgA and IgM antibodies to the SARS‐CoV‐2 spike glycoprotein in serum and saliva
SE Faustini, SE Jossi, M PerezToledo, AM Shields, JD Allen, Y Watanabe, ML Newby, A Cook, CR Willcox, M Salim, M Goodall, JL Heaney, E MarcialJuarez, GL Morley, B Torlinska, DC Wraith, TV Veenith, S Harding, S Jolles, MJ Ponsford, T Plant, A Huissoon, MK O'Shea, BE Willcox, MT Drayson, M Crispin, AF Cunningham, AG Richter
Immunology 2021
Safety and Considerations of the COVID-19 Vaccine Massive Deployment
J Li, M Song, D Guo, Y Yi
Virologica Sinica 2021
Resistance of SARS-CoV-2 variants to neutralization by convalescent plasma from early COVID-19 outbreak in Singapore
B Wang, YS Goh, T Prince, EZ Ngoh, SN Salleh, PX Hor, CY Loh, SW Fong, C Hartley, SY Tan, BE Young, YS Leo, DC Lye, S Maurer-Stroh, LF Ng, JA Hiscox, L Renia, CI Wang
npj Vaccines 2021
Antibodies to neutralising epitopes synergistically block the interaction of the receptor‐binding domain of SARS‐CoV‐2 to ACE 2
M Pandey, V Ozberk, S Eskandari, AO Shalash, MA Joyce, HA Saffran, CJ Day, A Lepletier, BL Spillings, JL Mills, A Calcutt, F Fan, JT Williams, DI Stanisic, L Hattingh, J Gerrard, M Skwarczynski, J Mak, MP Jennings, I Toth, DL Tyrrell, MF Good
IBMS BoneKEy 2021
Molecular Insights into the Crosstalk Between Immune Inflammation Nexus and SARS-CoV-2 Virus
P Bose, P Sunita, SP Pattanayak
Current Microbiology 2021
Phenotype, Susceptibility, Autoimmunity, and Immunotherapy Between Kawasaki Disease and Coronavirus Disease-19 Associated Multisystem Inflammatory Syndrome in Children
MR Chen, HC Kuo, YJ Lee, H Chi, SC Li, HC Lee, KD Yang
Frontiers in immunology 2021
SARS-CoV-2 vaccines strategies: a comprehensive review of phase 3 candidates
NC Kyriakidis, A López-Cortés, EV González, AB Grimaldos, EO Prado
npj Vaccines 2021
A review: Antibody-dependent enhancement in COVID-19: The not so friendly side of antibodies
GA Sánchez-Zuno, MG Matuz-Flores, G González-Estevez, F Nicoletti, FJ Turrubiates-Hernández, K Mangano, JF Muñoz-Valle
International journal of immunopathology and pharmacology 2021
When Immunity Kills: The Lessons of SARS-CoV-2 Outbreak
Y Taoufik, MG de Goër de Herve, S Corgnac, A Durrbach, F Mami-Chouaib
Frontiers in immunology 2021
Absence of Vaccine-enhanced Disease With Unexpected Positive Protection Against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by Inactivated Vaccine Given Within 3 Days of Virus Challenge in Syrian Hamster Model
C Li, YX Chen, FF Liu, AC Lee, Y Zhao, ZH Ye, JP Cai, H Chu, RQ Zhang, KH Chan, KH Chiu, DC Lung, S Sridhar, IF Hung, KK To, AJ Zhang, JF Chan, KY Yuen
Clinical Infectious Diseases 2021
Multisystem Inflammatory Syndrome in Children Related to SARS-CoV-2
S Esposito, N Principi
Pediatric Drugs 2021
Convalescent plasma therapy in B-cell-depleted and B-cell sufficient patients with life-threatening COVID-19 – A case series
J Erber, JR Wiessner, C Huberle, J Schneider, H Mijočević, D von Bomhard, P Luppa, RM Schmid, S Rasch, T Lahmer
Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis 2021
Linear epitope landscape of the SARS-CoV-2 Spike protein constructed from 1,051 COVID-19 patients
Y Li, M Ma, Q Lei, F Wang, W Hong, D Lai, H Hou, Z Xu, B Zhang, H Chen, C Yu, J Xue, Y Zheng, X Wang, H Jiang, H Zhang, H Qi, S Guo, Y Zhang, X Lin, Z Yao, J Wu, H Sheng, Y Zhang, H Wei, Z Sun, X Fan, S Tao
Cell Reports 2021
A single intranasal dose of chimpanzee adenovirus-vectored vaccine protects against SARS-CoV-2 infection in rhesus macaques
AO Hassan, F Feldmann, H Zhao, DT Curiel, A Okumura, TL Tang-Huau, JB Case, K Meade-White, J Callison, RE Chen, J Lovaglio, PW Hanley, DP Scott, DH Fremont, H Feldmann, MS Diamond
Cell reports. Medicine 2021
Clinical Characteristics of Paediatric Hyperinflammatory Syndrome in the Era of Corona Virus Disease 2019 (COVID-19)
M Basu, S Das
Indian Journal of Clinical Biochemistry 2021
Ferritin as a diagnostic, differential diagnostic, and prognostic marker for immune-related adverse events
W Zhang, Y Meng, L Yang, M Shen, L Zhou, R Li, Y Wang, W Du, Y Xiong, Y Han, X Zhang, L Liu, X Ren
Cancer biology & medicine 2021
Non-human primate models of human respiratory infections
J Lemaitre, T Naninck, B Delache, J Creppy, P Huber, M Holzapfel, C Bouillier, V Contreras, F Martinon, N Kahlaoui, Q Pascal, S Tricot, F Ducancel, L Vecellio, RL Grand, P Maisonnasse
Molecular Immunology 2021
Nanovesicles derived from bispecific CAR-T cells targeting the spike protein of SARS-CoV-2 for treating COVID-19
T Zhu, Y Xiao, X Meng, L Tang, B Li, Z Zhao, Q Tan, H Shan, L Liu,
Journal of nanobiotechnology 2021
Targets and strategies for vaccine development against SARS-CoV-2
JA Malik, AH Mulla, T Farooqi, FH Pottoo, S Anwar, KR Rengasamy
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2021
Comprehensive transcriptomic analysis of COVID-19 blood, lung, and airway
AR Daamen, P Bachali, KA Owen, KM Kingsmore, EL Hubbard, AC Labonte, R Robl, S Shrotri, AC Grammer, PE Lipsky
Scientific Reports 2021
The Fc-mediated effector functions of a potent SARS-CoV-2 neutralizing antibody, SC31, isolated from an early convalescent COVID-19 patient, are essential for the optimal therapeutic efficacy of the antibody
CE Chan, SG Seah, DH Chye, S Massey, M Torres, AP Lim, SK Wong, JJ Neo, PS Wong, JH Lim, GS Loh, D Wang, JD Boyd-Kirkup, S Guan, D Thakkar, GH Teo, K Purushotorman, PE Hutchinson, BE Young, JG Low, PA MacAry, H Hentze, VS Prativadibhayankara, K Ethirajulu, JE Comer, CT Tseng, AD Barrett, PJ Ingram, T Brasel, BJ Hanson, K Harrod
PloS one 2021
­­­­­­­A type I IFN, prothrombotic hyperinflammatory neutrophil signature is distinct for COVID-19 ARDS­­­
Reyes L, A. Sanchez-Garcia M, Morrison T, Howden AJ, Watts ER, Arienti S, Sadiku P, Coelho P, Mirchandani AS, Zhang A, Hope D, Clark SK, Singleton J, Johnston S, Grecian R, Poon A, McNamara S, Harper I, Fourman MH, Brenes AJ, Pathak S, Lloyd A, Blanco GR, von Kriegsheim A, Ghesquiere B, Vermaelen W, Cologna CT, Dhaliwal K, Hirani N, Dockrell DH, Whyte MK, Griffith D, Cantrell DA, Walmsley SR
Wellcome Open Research 2021
Severe Acute Respiratory Syndrome Coronavirus-2 Infection and Autoimmunity 1 Year Later: The Era of Vaccines.
Picchianti Diamanti A, Rosado MM, Nicastri E, Sesti G, Pioli C, Laganà B
Frontiers in immunology 2021
Characteristics of COVID-19 Patients Based on the Results of Nucleic Acid and Specific Antibodies and the Clinical Relevance of Antibody Levels
Chen H, Qin R, Huang Z, He L, Luo W, Zheng P, Huang H, Wang H, Sun B
Frontiers in Molecular Biosciences 2021
Robust SARS-CoV-2 infection in nasal turbinates after treatment with systemic neutralizing antibodies
Zhou D, Chan JF, Zhou B, Zhou R, Li S, Shan S, Liu L, Zhang AJ, Chen SJ, Chan CC, Xu H, Poon VK, Yuan S, Li C, Chik KK, Chan CC, Cao J, Chan CY, Kwan KY, Du Z, Lau TT, Zhang Q, Zhou J, To KK, Zhang L, Ho DD, Yuen KY, Chen Z
Cell Host & Microbe 2021
COVID-19: Imbalanced Immune Responses and Potential Immunotherapies.
Xie B, Zhang J, Li Y, Yuan S, Shang Y
Frontiers in immunology 2021
A review on the immune responses against novel emerging coronavirus (SARS-CoV-2).
Lotfi R, Kalmarzi RN, Roghani SA
Immunologic research 2021
Overview of Nonhuman Primate Models of SARS-CoV-2
Trichel AM
Comparative medicine 2021
Perspectives About Modulating Host Immune System in Targeting SARS-CoV-2 in India.
Majumdar S, Verma R, Saha A, Bhattacharyya P, Maji P, Surjit M, Kundu M, Basu J, Saha S
Frontiers in Genetics 2021
Humoral immune mechanisms involved in protective and pathological immunity during COVID-19.
Widjaja G, Turki Jalil A, Sulaiman Rahman H, Abdelbasset WK, Bokov DO, Suksatan W, Ghaebi M, Marofi F, Gholizadeh Navashenaq J, Jadidi-Niaragh F, Ahmadi M
Human Immunology 2021
Evaluation of the relationship between macrophage migration inhibitory factor level and clinical course in patients with COVID-19 pneumonia.
Aksakal A, Kerget B, Kerget F, Aşkın S
Journal of Medical Virology 2021
Asymptomatic COVID-19 re-infection in a Japanese male by elevated half-maximal inhibitory concentration (IC50) of neutralizing antibodies
Inada M, Ishikane M, Terada M, Matsunaga A, Maeda K, Tsuchiya K, Miura K, Sairenji Y, Kinoshita N, Ujiie M, Kutsuna S, Ishizaka Y, Mitsuya H, Ohmagari N
Journal of Infection and Chemotherapy 2021
Structure and function analysis of a potent human neutralizing antibody CA521FALA against SARS-CoV-2
Song D, Wang W, Dong C, Ning Z, Liu X, Liu C, Du G, Sha C, Wang K, Lu J, Sun B, Zhao Y, Wang Q, Xu H, Li Y, Shen Z, Jiao J, Wang R, Tian J, Liu W, Wang L, Deng YQ, Dou C
2021
SARS-CoV-2 spike glycoprotein vaccine candidate NVX-CoV2373 immunogenicity in baboons and protection in mice
Tian JH, Patel N, Haupt R, Zhou H, Weston S, Hammond H, Logue J, Portnoff AD, Norton J, Guebre-Xabier M, Zhou B, Jacobson K, Maciejewski S, Khatoon R, Wisniewska M, Moffitt W, Kluepfel-Stahl S, Ekechukwu B, Papin J, Boddapati S, Jason Wong C, Piedra PA, Frieman MB, Massare MJ, Fries L, Bengtsson KL, Stertman L, Ellingsworth L, Glenn G, Smith G
Nature Communications 2021
Site-specific N-glycosylation Characterization of Recombinant SARS-CoV-2 Spike Proteins
Zhang Y, Zhao W, Mao Y, Chen Y, Wang S, Zhong Y, Su T, Gong M, Du D, Lu X, Cheng J, Yang H
Molecular & cellular proteomics : MCP 2021
Temporal viral loads in respiratory and gastrointestinal tract and serum antibody responses during SARS-CoV-2 infection in an Italian pediatric cohort
Caccuri F, Bugatti A, Meini A, Bonfanti C, Motta M, Savarè L, Arrighini A, Bondioni MP, Lougaris V, Caruso A, Plebani A
Clinical Immunology 2021
COVID-19 vaccines: Frequently asked questions and updated answers
Lefebvre M, Vignier N, Pitard B, Botelho-Nevers E, Wyplosz B, Cohen R, Epaulard O
2021
Identification of HLA-A*02:01-Restricted Candidate Epitopes Derived from the Nonstructural Polyprotein 1a of SARS-CoV-2 That May Be Natural Targets of CD8+ T Cell Recognition In Vivo
Takagi A, Matsui M
Journal of virology 2021
A Nanoscaffolded Spike-RBD Vaccine Provides Protection against SARS-CoV-2 with Minimal Anti-Scaffold Response
Lainšček D, Fink T, Forstnerič V, Hafner-Bratkovič I, Orehek S, Strmšek Ž, Manček-Keber M, Pečan P, Esih H, Malenšek Š, Aupič J, Dekleva P, Plaper T, Vidmar S, Kadunc L, Benčina M, Omersa N, Anderluh G, Pojer F, Lau K, Hacker D, Correia BE, Peterhoff D, Wagner R, Bergant V, Herrmann A, Pichlmair A, Jerala R
Human vaccines 2021
SARS-CoV-2: Unique Challenges of the Virus and Vaccines
Mahmoodpoor A, Sanaie S, Samadi P, Yousefi M, Nader ND
Immunological Investigations 2021
Liver Disease and Coronavirus Disease 2019: From Pathogenesis to Clinical Care
Saviano A, Wrensch F, Ghany MG, Baumert TF
Hepatology 2021
A SARS-CoV-2 neutralizing antibody selected from COVID-19 patients binds to the ACE2-RBD interface and is tolerant to most known RBD mutations
Bertoglio F, Fühner V, Ruschig M, Heine PA, Abassi L, Klünemann T, Rand U, Meier D, Langreder N, Steinke S, Ballmann R, Schneider KT, Roth KD, Kuhn P, Riese P, Schäckermann D, Korn J, Koch A, Chaudhry MZ, Eschke K, Kim Y, Zock-Emmenthal S, Becker M, Scholz M, Moreira GM, Wenzel EV, Russo G, Garritsen HS, Casu S, Gerstner A, Roth G, Adler J, Trimpert J, Hermann A, Schirrmann T, Dübel S, Frenzel A, Van den Heuvel J, Čičin-Šain L, Schubert M, Hust M
Cell Reports 2021
Characterization of MW06, a human monoclonal antibody with cross-neutralization activity against both SARS-CoV-2 and SARS-CoV
Jiang W, Wang J, Jiao S, Gu C, Xu W, Chen B, Wang R, Chen H, Xie Y, Wang A, Li G, Zeng D, Zhang J, Zhang M, Wang S, Wang M, Gui X
mAbs 2021
Antibody indexes in COVID-19 convalescent plasma donors: Unanswered questions
Bonetti TC, Latini FR, Invitti AL, Fonseca MC, Scorza FA, Saldanha MG, Bellucco FT, Bacarov NB, Soane MM, Girão MJ
Clinics 2021
Distinguishing features of current COVID-19 vaccines: knowns and unknowns of antigen presentation and modes of action
Heinz FX, Stiasny K
npj Vaccines 2021
Antibody dependent enhancement: Unavoidable problems in vaccine development
Xu L, Ma Z, Li Y, Pang Z, Xiao S
Advances in immunology 2021
Profile of Immunoglobulin G N-Glycome in COVID-19 Patients: A Case-Control Study
Hou H, Yang H, Liu P, Huang C, Wang M, Li Y, Zhu M, Wang J, Xu Y, Wang Y, Ma Q, Li D, Liao P, Wang W
Frontiers in immunology 2021
Non-clinical safety assessment and in vivo biodistribution of CoviFab, an RBD-specific F(ab′)2 fragment derived from equine polyclonal antibodies
Salinas F, Marelli BE, Sanguineti S, Goldbaum F, Muñoz L, Etchevers L, Silvestrini P, Notaro US, Salvetti NR, Zylberman V, Ortega HH
Toxicology and Applied Pharmacology 2021
Development of an Inactivated Vaccine against SARS CoV-2
Pavel ST, Yetiskin H, Uygut MA, Aslan AF, Aydın G, İnan Ö, Kaplan B, Ozdarendeli A
Human vaccines 2021
COVID-19 Pandemic and Vaccines Update on Challenges and Resolutions.
Khan WH, Hashmi Z, Goel A, Ahmad R, Gupta K, Khan N, Alam I, Ahmed F, Ansari MA
Frontiers in Cellular and Infection Microbiology 2021
Prevalence of SARS-CoV-2 antibodies in the Palestinian population: A primary health center-based cross-sectional study.
Maraqa B, Basha W, Khayyat R, Abdul-Hadi AR, Jabareen J, Al-Shakhra K, Al-Kaila M, Nazzal Z
PloS one 2021
Development of the Inactivated QazCovid-in Vaccine: Protective Efficacy of the Vaccine in Syrian Hamsters.
Zhugunissov K, Zakarya K, Khairullin B, Orynbayev M, Abduraimov Y, Kassenov M, Sultankulova K, Kerimbayev A, Nurabayev S, Myrzakhmetova B, Nakhanov A, Nurpeisova A, Chervyakova O, Assanzhanova N, Burashev Y, Mambetaliyev M, Azanbekova M, Kopeyev S, Kozhabergenov N, Issabek A, Tuyskanova M, Kutumbetov L
Frontiers in microbiology 2021
Enhanced protective immunity against SARS-CoV-2 elicited by a VSV vector expressing a chimeric spike protein.
Li H, Zhang Y, Li D, Deng YQ, Xu H, Zhao C, Liu J, Wen D, Zhao J, Li Y, Wu Y, Liu S, Liu J, Hao J, Yuan F, Duo S, Qin CF, Zheng A
Signal Transduction and Targeted Therapy 2021
Activating endogenous resolution pathways by soluble epoxide hydrolase inhibitors for the management of COVID-19.
Manickam M, Meenakshisundaram S, Pillaiyar T
Archiv der Pharmazie 2021
Covid-19 pandemic: What is the truth?
Blaylock RL
Surgical neurology international 2021
Polymersomes Decorated with the SARS-CoV-2 Spike Protein Receptor-Binding Domain Elicit Robust Humoral and Cellular Immunity
Volpatti LR, Wallace RP, Cao S, Raczy MM, Wang R, Gray LT, Alpar AT, Briquez PS, Mitrousis N, Marchell TM, Sasso MS, Nguyen M, Mansurov A, Budina E, Solanki A, Watkins EA, Schnorenberg MR, Tremain AC, Reda JW, Nicolaescu V, Furlong K, Dvorkin S, Yu SS, Manicassamy B, LaBelle JL, Tirrell MV, Randall G, Kwissa M, Swartz MA, Hubbell JA
ACS Central Science 2021
COVID-19 Vaccine: Critical Questions with Complicated Answers
Haidere MF, Ratan ZA, Nowroz S, Zaman SB, Jung YJ, Hosseinzadeh H, Cho JY
Biomolecules & therapeutics 2021
The 2020 race towards SARS-CoV-2 specific vaccines
Karpiński TM, Ożarowski M, Seremak-Mrozikiewicz A, Wolski H, Wlodkowic D
Theranostics 2021
Childhood Multisystem Inflammatory Syndrome: An Emerging Disease with Prominent Cardiovascular Involvement—A Scoping Review
Malviya A, Mishra A
2021
Clinical analysis and pluripotent stem cells-based model reveal possible impacts of ACE2 and lung progenitor cells on infants vulnerable to COVID-19
Zhang Z, Guo L, Lu X, Zhang C, Huang L, Wang X, Duan F, Liang H, Chen P, Zeng L, Shao J, Li H, Li L, Liu L, Li C, Zhang J, Ma CY, Kwan KY, Liu W, Xu Y, Gu X, Jiang H, Du H, Zhang T, Wu Y, Yu G, Chen J, Luo R, Liao C, Tse HF, Chen Z, Chen HJ, Xia H, Lian Q
Theranostics 2021
Structural Analysis of Neutralizing Epitopes of the SARS-CoV-2 Spike to Guide Therapy and Vaccine Design Strategies
Finkelstein MT, Mermelstein AG, Parker Miller E, Seth PC, Stancofski ES, Fera D
Viruses 2021
Identification of SARS-CoV-2 CTL epitopes for development of a multivalent subunit vaccine for COVID-19
Rencilin CF, Rosy JC, Mohan M, Coico R, Sundar K
Infection, Genetics and Evolution 2021
Exploring beyond clinical routine SARS-CoV-2 serology using MultiCoV-Ab to evaluate endemic coronavirus cross-reactivity
Becker M, Strengert M, Junker D, Kaiser PD, Kerrinnes T, Traenkle B, Dinter H, Häring J, Ghozzi S, Zeck A, Weise F, Peter A, Hörber S, Fink S, Ruoff F, Dulovic A, Bakchoul T, Baillot A, Lohse S, Cornberg M, Illig T, Gottlieb J, Smola S, Karch A, Berger K, Rammensee HG, Schenke-Layland K, Nelde A, Märklin M, Heitmann JS, Walz JS, Templin M, Joos TO, Rothbauer U, Krause G, Schneiderhan-Marra N
Nature Communications 2021
Prolonged SARS-CoV-2 cell culture replication in respiratory samples from patients with severe COVID-19
Folgueira MD, Luczkowiak J, Lasala F, Pérez-Rivilla A, Delgado R
Clinical Microbiology and Infection 2021
Rational Design of a Pan-Coronavirus Vaccine Based on Conserved CTL Epitopes
Li M, Zeng J, Li R, Wen Z, Cai Y, Wallin J, Shu Y, Du X, Sun C
Viruses 2021
The significance of bioengineered nanoplatforms against SARS-CoV-2: From detection to genome editing
Hassanzadeh P
Life Sciences 2021
SARS-CoV-2 vaccines: A critical perspective through efficacy data and barriers to herd immunity
Blasi F, Gramegna A, Sotgiu G, Saderi L, Voza A, Aliberti S, Amati F
Respiratory Medicine 2021
Next generation of anti-PD-L1 Atezolizumab with enhanced anti-tumor efficacy in vivo
Li M, Zhao R, Chen J, Tian W, Xia C, Liu X, Li Y, Li S, Sun H, Shen T, Ren W, Sun L
Scientific Reports 2021
SARS-CoV-2-induced humoral immunity through B cell epitope analysis in COVID-19 infected individuals
Yoshida S, Ono C, Hayashi H, Fukumoto S, Shiraishi S, Tomono K, Arase H, Matsuura Y, Nakagami H
Scientific Reports 2021
SARS‐CoV‐2‐related multisystem inflammatory syndrome in an immunocompromised child with leukemia
Pandrowala A, Panchal H, Mudaliar S, Bodhanwala M, Prabhu S, Jain S, Mishra J, Hiwarkar P
Pediatric Blood & Cancer 2021
Simultaneous CD8+ T-Cell Immune Response against SARS-Cov-2 S, M, and N Induced by Endogenously Engineered Extracellular Vesicles in Both Spleen and Lungs
Ferrantelli F, Chiozzini C, Manfredi F, Giovannelli A, Leone P, Federico M
Human vaccines 2021
Is SARS-CoV-2 Spike glycoprotein impairing macrophage function via α7-nicotinic acetylcholine receptors?
Tanmay S, Labrou D, Farsalinos K, Poulas K
Food and Chemical Toxicology 2021
Conformational Changes of the Receptor Binding Domain of SARS-CoV-2 Spike Protein and Prediction of a B-Cell Antigenic Epitope Using Structural Data
Khare S, Azevedo M, Parajuli P, Gokulan K
2021
RBD-specific polyclonal F(ab´)2 fragments of equine antibodies in patients with moderate to severe COVID-19 disease: A randomized, multicenter, double-blind, placebo-controlled, adaptive phase 2/3 clinical trial
Lopardo G, Belloso WH, Nannini E, Colonna M, Sanguineti S, Zylberman V, Muñoz L, Dobarro M, Lebersztein G, Farina J, Vidiella G, Bertetti A, Crudo F, Alzogaray MF, Barcelona L, Teijeiro R, Lambert S, Scublinsky D, Iacono M, Stanek V, Solari R, Cruz P, Casas MM, Abusamra L, Luciardi HL, Cremona A, Caruso D, de Miguel B, Lloret SP, Millán S, Kilstein Y, Pereiro A, Sued O, Cahn P, Spatz L, Goldbaum F
2021
Application of a recombinant replicase to localize the Trionyx sinensis hemorrhagic syndrome virus and evaluate its effects on antiviral genes of T. sinensis
LYU S, YUAN X, LIU L, ZHANG H, YU Z, HANG X, SHI W, WU Y
Journal of Zhejiang University. Science. B 2021
Diagnostic performance of an automated chemiluminescence immunoassay for SARS-CoV-2 IgG and IgM antibodies detection: A real life experience
Villalta D, Martelli P, Moratto A, Salgarolo V, Ligato E, Conte M, Giacomello R, Pellis T, De Rosa R, Venturini S, Crapis M
Practical Laboratory Medicine 2021
An Overview of Spike Surface Glycoprotein in Severe Acute Respiratory Syndrome–Coronavirus
Kathiravan MK, Radhakrishnan S, Namasivayam V, Palaniappan S
Frontiers in Molecular Biosciences 2021
CpG-adjuvanted stable prefusion SARS-CoV-2 spike protein protected hamsters from SARS-CoV-2 challenge
Lien CE, Lin YJ, Chen C, Lian WC, Kuo TY, Campbell JD, Traquina P, Lin MY, Liu LT, Chuang YS, Ko HY, Liao CC, Chen YH, Jan JT, Ma HH, Sun CP, Lin YS, Wu PY, Wang YC, Tao MH, Lin YL
Scientific Reports 2021
Pharmaceutical Aspects and Clinical Evaluation of COVID-19 Vaccines
Hofman K, Shenoy GN, Chak V, Balu-Iyer SV
Immunological Investigations 2021
Development and characterization of two equine formulations towards SARS-CoV-2 proteins for the potential treatment of COVID-19
León G, Herrera M, Vargas M, Arguedas M, Sánchez A, Segura Á, Gómez A, Solano G, Corrales-Aguilar E, Risner K, Narayanan A, Bailey C, Villalta M, Hernández A, Sánchez A, Cordero D, Solano D, Durán G, Segura E, Cerdas M, Umaña D, Moscoso E, Estrada R, Gutiérrez J, Méndez M, Castillo AC, Sánchez L, Sánchez R, Gutiérrez JM, Díaz C, Alape A
Scientific Reports 2021
Comparative systematic review and meta-analysis of reactogenicity, immunogenicity and efficacy of vaccines against SARS-CoV-2
McDonald I, Murray SM, Reynolds CJ, Altmann DM, Boyton RJ
npj Vaccines 2021
A novel mouse AAV6 hACE2 transduction model of wild-type SARS-CoV-2 infection studied using synDNA immunogens
Gary EN, Warner BM, Parzych EM, Griffin BD, Zhu X, Tailor N, Tursi NJ, Chan M, Purwar M, Vendramelli R, Choi J, Frost KL, Reeder S, Liaw K, Tello E, Ali AR, Yun K, Pei Y, Thomas SP, Rghei AD, Guilleman MM, Muthumani K, Smith T, Wootton SK, Patel A, Weiner DB, Kobasa D
iScience 2021
A recombinant receptor-binding domain in trimeric form generates protective immunity against SARS-CoV-2 infection in nonhuman primates
Yang L, Tian D, Han JB, Fan W, Zhang Y, Li Y, Sun W, Wei Y, Tian X, Yu DD, Feng XL, Cheng G, Bi Y, Zheng YT, Liu W
2021
What gastroenterologists should know about SARS–CoV 2 vaccine: World Endoscopy Organization perspective
Spadaccini M, Canziani L, Aghemo A, Lleo A, Maselli R, Anderloni A, Carrara S, Fugazza A, Pellegatta G, Galtieri PA, Hassan C, Greenwald D, Pochapin M, Wallace M, Sharma P, Roesch T, Bhandari P, Emura F, Raju GS, Repici A
United European gastroenterology journal 2021
Capturing Cytokines with Advanced Materials: A Potential Strategy to Tackle COVID‐19 Cytokine Storm
Meng Q, Tian R, Long H, Wu X, Lai J, Zharkova O, Wang J, Chen X, Rao L
Advanced materials (Deerfield Beach, Fla.) 2021
Regulatory concepts to guide and promote the accelerated but safe clinical development and licensure of COVID‐19 vaccines in Europe
Wagner R, Meißner J, Grabski E, Sun Y, Vieths S, Hildt E
Allergy 2021
Immune cell profiling and antibody responses in patients with COVID-19
Rezaei M, Mahmoudi S, Mortaz E, Marjani M
BMC Infectious Diseases 2021
SARS-CoV-2 Infection in the Immunodeficient Host: Necessary and Dispensable Immune Pathways
Giardino G, Romano R, Coppola E, Cillo F, Borzachiello C, De Luca M, Palamaro L, Toriello E, Prencipe R, Cirillo E, Pignata C
The journal of allergy and clinical immunology. In practice 2021
Tolerability, Safety, Pharmacokinetics, and Immunogenicity of a Novel SARS-CoV-2 Neutralizing Antibody, Etesevimab, in Chinese Healthy Adults: a Randomized, Double-Blind, Placebo-Controlled, First-in-Human Phase 1 Study
Wu X, Li N, Wang G, Liu W, Yu J, Cao G, Wang J, Chen Y, Ma J, Wu J, Yang H, Mao X, He J, Yu Y, Qiu C, Li N, Yao S, Feng H, Yan J, Zhang W, Zhang J
Antimicrobial agents and chemotherapy 2021
Accelerated Development of COVID-19 Vaccines: Technology Platforms, Benefits, and Associated Risks
Wagner R, Hildt E, Grabski E, Sun Y, Meyer H, Lommel A, Keller-Stanislawski B, Müller-Berghaus J, Cichutek K
Human vaccines 2021
SARS-CoV-2 Vaccines Based on the Spike Glycoprotein and Implications of New Viral Variants
Martínez-Flores D, Zepeda-Cervantes J, Cruz-Reséndiz A, Aguirre-Sampieri S, Sampieri A, Vaca L
Frontiers in immunology 2021
Analysis of the dynamic relationship between immune profiles and the clinical features of patients with COVID-19
Ren P, Zhu C, He Y, Jiang H, Chen J
Annals of translational medicine 2021
Factors Affecting the Antibody Immunogenicity of Vaccines against SARS-CoV-2: A Focused Review
Cheng ZJ, Xue M, Zheng P, Lyu J, Zhan Z, Hu H, Zhang Y, Zhang XD, Sun B
Human vaccines 2021
Rapid generation of mouse model for emerging infectious disease with the case of severe COVID-19
Sun CP, Jan JT, Wang IH, Ma HH, Ko HY, Wu PY, Kuo TJ, Liao HN, Lan YH, Sie ZL, Chen YH, Ko YA, Liao CC, Chen LY, Lee IJ, Tsung SI, Lai YJ, Chiang MT, Liang JJ, Liu WC, Wang JR, Yuan JP, Lin YS, Tsai YC, Hsieh SL, Li CW, Wu HC, Ko TM, Lin YL, Tao MH
PLoS pathogens 2021
Astaxanthin protective barrier and its ability to improve the health in patients with COVID-19
Ahmadi AR, Ayazi-Nasrabadi R
Iranian Journal of Microbiology 2021
The self-assembled nanoparticle-based trimeric RBD mRNA vaccine elicits robust and durable protective immunity against SARS-CoV-2 in mice
Sun W, He L, Zhang H, Tian X, Bai Z, Sun L, Yang L, Jia X, Bi Y, Luo T, Cheng G, Fan W, Liu W, Li J
Signal Transduction and Targeted Therapy 2021
Anti-SARS-CoV-2 IgG and IgA antibodies in COVID-19 convalescent plasma do not facilitate antibody-dependent enhance of viral infection.
Clark NM, Janaka SK, Hartman W, Stramer S, Goodhue E, Weiss J, Evans DT, Connor JP
2021
Recent SARS-CoV-2 Outlook and Implications in a COVID-19 Vaccination Era
Ehianeta T, Mzee SA, Adebisi MK, Ehianeta O
2021
Impact of rituximab on COVID-19 outcomes
Levavi H, Lancman G, Gabrilove J
Annals of Hematology 2021
Early insight into antibody-dependent enhancement after SARS-CoV-2 mRNA vaccination
Hasan A, Al-Mulla MR, Abubaker J, Al-Mulla F
Human Vaccines & Immunotherapeutics 2021
Polymersomes decorated with SARS-CoV-2 spike protein receptor binding domain elicit robust humoral and cellular immunity.
Volpatti LR, Wallace RP, Cao S, Raczy MM, Wang R, Gray LT, Alpar AT, Briquez PS, Mitrousis N, Marchell TM, Sasso MS, Nguyen M, Mansurov A, Budina E, Solanki A, Watkins EA, Schnorenberg MR, Tremain AC, Reda JW, Nicolaescu V, Furlong K, Dvorkin S, Yu SS, Manicassamy B, LaBelle JL, Tirrell MV, Randall G, Kwissa M, Swartz MA, Hubbell JA
bioRxiv : the preprint server for biology 2021
Distinctive features of SARS-CoV-2-specific T cells predict recovery from severe COVID-19
Neidleman J, Luo X, George AF, McGregor M, Yang J, Yun C, Murray V, Gill G, Greene WC, Vasquez J, Lee S, Ghosn E, Lynch K, Roan NR
2021
COVID-19 associated multisystem inflammatory syndrome in children mimicking acute appendicitis - how to differentiate and conduct pediatric patients during the pandemic? - Proposal of a management flowchart
FALQUETO LE, VISSOCI CM, FERREIRA IC, ANTUNES AG, AMADO FA, AVILLA SA, SCHULZ C, MOTTA FA, SILVA ED
Revista do Colégio Brasileiro de Cirurgiões 2021
Early Safety Indicators of COVID-19 Convalescent Plasma in 5,000 Patients
Michael J. Joyner, R. Scott Wright, DeLisa Fairweather, Jonathon W. Senefeld, Katelyn A. Bruno, Stephen A. Klassen, Rickey E. Carter, Allan M. Klompas, Chad C. Wiggins, John R.A. Shepherd, Robert F. Rea, Emily R. Whelan, Andrew J. Clayburn, Matthew R. Spiegel, Patrick W. Johnson, Elizabeth R. Lesser, Sarah E. Baker, Kathryn F. Larson, Juan G. Ripoll, Kylie J. Andersen, David O. Hodge, Katie L. Kunze, Matthew R. Buras, Matthew N.P. Vogt, Vitaly Herasevich, Joshua J. Dennis, Riley J. Regimbal, Philippe R. Bauer, Janis E. Blair, Camille M. van Buskirk, Jeffrey L. Winters, James R. Stubbs, Nigel S. Paneth, Nicole C. Verdun, Peter Marks, Arturo Casadevall
Journal of Clinical Investigation 2020
Serum interleukin-6 is an indicator for severity in 901 patients with SARS-CoV-2 infection: a cohort study
J Zhang, Y Hao, W Ou, F Ming, G Liang, Y Qian, Q Cai, S Dong, S Hu, W Wang, S Wei
Journal of Translational Medicine 2020
Detection of antibodies to the SARS-CoV-2 spike glycoprotein in both serum and saliva enhances detection of infection
Sian E Faustini, Sian E Jossi, Marisol Perez-Toledo, Adrian Shields, Joel D Allen, Yasunori Watanabe, Maddy L Newby, Alex Cook, Carrie R Willcox, Mahboob Salim, Margaret Goodall, Jennifer L Heaney, Edith Marcial-Juarez, Gabriella L Morley, Barbara Torlinska, David C Wraith, Tonny Veenith, Stephen Harding, Stephen Jolles, Ponsford J Mark, Tim Plant, Aarnoud Huissoon, Matthew K O'Shea, Benjamin E Willcox, Mark T Drayson, Max Crispin, Adam F Cunningham, Alex G Richter
Persistent lentivirus infection induces early myeloid suppressor cells expansion to subvert protective memory CD8 T cell response✰,✰✰
L Liu, Q Lin, J Peng, J Fang, Z Tan, H Tang, K Kwan, K Nishiura, J Liang, H Kwok, Z Du, J Sun, K Liu, KY Yuen, H Wang, Z Chen
EBioMedicine 2020
Early Humoral Response Correlates with Disease Severity and Outcomes in COVID-19 Patients
AM Hashem, A Algaissi, SA Almahboub, MA Alfaleh, TS Abujamel, SS Alamri, KA Alluhaybi, HI Hobani, RH AlHarbi, RM Alsulaiman, MZ ElAssouli, S Hala, NK Alharbi, RY Alhabbab, AA AlSaieedi, WH Abdulaal, A Bukhari, AA AL-Somali, FS Alofi, AA Khogeer, A Pain, AA Alkayyal, NA Almontashiri, BM Ahmad, X Li
Viruses 2020
From Anti-SARS-CoV-2 Immune Responses to COVID-19 via Molecular Mimicry
D Kanduc
Antibodies 2020
Why does COVID-19 disproportionately affect older people?
AL Mueller, MS McNamara, DA Sinclair
Aging 2020
I mmunosenescence and Inflammaging: Risk Factors of Severe COVID-19 in Older People
AJ Pietrobon, FM Teixeira, MN Sato
Frontiers in immunology 2020
Autoinflammatory and autoimmune conditions at the crossroad of COVID-19
Y Rodríguez, L Novelli, M Rojas, MD Santis, Y Acosta-Ampudia, DM Monsalve, C Ramírez-Santana, A Costanzo, WM Ridgway, AA Ansari, ME Gershwin, C Selmi, JM Anaya
Journal of Autoimmunity 2020
COVID‐19, varying genetic resistance to viral disease and immune tolerance checkpoints
CC Goodnow
Immunology and Cell Biology 2020
Mitigating Coronavirus Induced Dysfunctional Immunity for At-Risk Populations in COVID-19: Trained Immunity, BCG and “New Old Friends”
TO Kleen, AA Galdon, AS MacDonald, AG Dalgleish
Frontiers in immunology 2020
Part II. high-dose methotrexate with leucovorin rescue for severe COVID-19: An immune stabilization strategy for SARS-CoV-2 induced ‘PANIC’ attack
EM Frohman, NR Villemarette-Pittman, RA Cruz, R Longmuir, V Rowe, ES Rowe, TC Varkey, L Steinman, SS Zamvil, TC Frohman
Journal of the Neurological Sciences 2020
COVID-19 antibodies on trial
L DeFrancesco
Nature Biotechnology 2020
Mechanistic inferences from clinical reports of SARS-CoV-2
MM Jenkins, TR McCaw, PA Goepfert
Infectious Diseases 2020
High-Dose Intravenous Immunoglobulins in the Treatment of Severe Acute Viral Pneumonia: The Known Mechanisms and Clinical Effects
X Liu, W Cao, T Li
Frontiers in immunology 2020
Vaccines for COVID-19: perspectives from nucleic acid vaccines to BCG as delivery vector system
NM de Queiroz, FV Marinho, MA Chagas, LC Leite, EJ Homan, MT de Magalhães, SC Oliveira
Microbes and infection / Institut Pasteur 2020
The role of IgG Fc receptors in antibody-dependent enhancement
S Bournazos, A Gupta, JV Ravetch
Nature Reviews Immunology 2020
Merits and culprits of immunotherapies for neurological diseases in times of COVID-19
M Pawlitzki, UK Zettl, T Ruck, L Rolfes, HP Hartung, SG Meuth
EBioMedicine 2020
Mechanisms of Dysregulated Humoral and Cellular Immunity by SARS-CoV-2
N Taefehshokr, S Taefehshokr, B Heit
Pathogens 2020
Identification of a metabolic gene panel to predict the prognosis of myelodysplastic syndrome
F Hu, S Chen, Y Dai, Y Wang, Z Qin, H Li, L Shu, J Li, H Huang, Y Liang
Journal of Cellular and Molecular Medicine 2020
Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages
M Merad, JC Martin
Nature Reviews Immunology 2020
Immunometabolic Status of COVID-19 Cancer Patients
A Sica, MP Colombo, A Trama, L Horn, MC Garassino, V Torri
Physiological reviews 2020
The trinity of COVID-19: immunity, inflammation and intervention
MZ Tay, CM Poh, L Rénia, PA MacAry, LF Ng
Nature Reviews Immunology 2020
Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals
A Grifoni, D Weiskopf, SI Ramirez, J Mateus, JM Dan, CR Moderbacher, SA Rawlings, A Sutherland, L Premkumar, RS Jadi, D Marrama, AM de Silva, A Frazier, AF Carlin, JA Greenbaum, B Peters, F Krammer, DM Smith, S Crotty, A Sette
Cell 2020
Gaining insights on immune responses to the novel coronavirus, COVID-19 and therapeutic challenges
M Hajivalili, M Hosseini, M Haji-Fatahaliha
Life Sciences 2020
Lessons for COVID-19 Immunity from Other Coronavirus Infections
A Sariol, S Perlman
Immunity 2020
Immune responses during COVID-19 infection
C Melenotte, A Silvin, AG Goubet, I Lahmar, A Dubuisson, A Zumla, D Raoult, M Merad, B Gachot, C Hénon, E Solary, M Fontenay, F André, M Maeurer, G Ippolito, M Piacentini, FS Wang, F Ginhoux, A Marabelle, G Kroemer, L Derosa, L Zitvogel
OncoImmunology 2020
The Comparative Immunological Characteristics of SARS-CoV, MERS-CoV, and SARS-CoV-2 Coronavirus Infections
Y Zhang, B Li, B Ning
Frontiers in immunology 2020
Immunology of COVID‐19: Mechanisms, clinical outcome, diagnostics, and perspectives—A report of the European Academy of Allergy and Clinical Immunology (EAACI)
M Sokolowska, ZM Lukasik, I Agache, CA Akdis, D Akdis, M Akdis, W Barcik, HA Brough, T Eiwegger, A Eljaszewicz, S Eyerich, W Feleszko, C GomezCasado, K HoffmannSommergruber, J Janda, R JiménezSaiz, M Jutel, EF Knol, IK Krohn, A Kothari, J Makowska, M Moniuszko, H Morita, L O'Mahony, K Nadeau, C Ozdemir, I PaliSchöll, O Palomares, F Papaleo, M Prunicki, CB SchmidtWeber, A Sediva, J Schwarze, MH Shamji, GA TramperStranders, W Veen, E Untersmayr
Allergy 2020
Immunology of COVID‐19 and disease‐modifying therapies: the good, the bad and the unknown
T Zrzavy, I Wimmer, PS Rommer, T Berger
European journal of neurology : the official journal of the European Federation of Neurological Societies 2020
Facing SARS-CoV-2 outbreak in immunotherapy era
F Citarella, M Russano, F Pantano, E Dell'Aquila, B Vincenzi, G Tonini, D Santini
Future Oncology 2020
Nanotechnology for COVID-19: Therapeutics and Vaccine Research
G Chauhan, MJ Madou, S Kalra, V Chopra, D Ghosh, SO Martinez-Chapa
ACS Nano 2020
The potential danger of suboptimal antibody responses in COVID-19
A Iwasaki, Y Yang
Nature Reviews Immunology 2020
Antibody-dependent enhancement and SARS-CoV-2 vaccines and therapies
WS Lee, AK Wheatley, SJ Kent, BJ DeKosky
Nature Microbiology 2020
Linear B-cell epitopes in the spike and nucleocapsid proteins as markers of SARS-CoV-2 exposure and disease severity
SN Amrun, CY Lee, B Lee, SW Fong, BE Young, RS Chee, NK Yeo, A Torres-Ruesta, G Carissimo, CM Poh, ZW Chang, MZ Tay, YH Chan, MI Chen, JG Low, PA Tambyah, S Kalimuddin, S Pada, SY Tan, LJ Sun, YS Leo, DC Lye, L Renia, LF Ng
EBioMedicine 2020
The lethal sex gap: COVID-19
EJ Márquez, J Trowbridge, GA Kuchel, J Banchereau, D Ucar
Immunity & Ageing 2020
Immune asynchrony in COVID-19 pathogenesis and potential immunotherapies
T Zhou, TT Su, T Mudianto, J Wang
Journal of Experimental Medicine 2020
Acute SARS-CoV-2 Infection Impairs Dendritic Cell and T Cell Responses
R Zhou, KK To, YC Wong, L Liu, B Zhou, X Li, H Huang, Y Mo, TY Luk, TT Lau, P Yeung, WM Chan, AK Wu, KC Lung, OT Tsang, WS Leung, IF Hung, KY Yuen, Z Chen
Immunity 2020
Implications of COVID-19 in pediatric rheumatology
ED Batu, S Özen
Rheumatology International 2020
Impact of immune enhancement on Covid-19 polyclonal hyperimmune globulin therapy and vaccine development
R de Alwis, S Chen, ES Gan, EE Ooi
EBioMedicine 2020
Immunology of COVID-19: Current State of the Science
N Vabret, GJ Britton, C Gruber, S Hegde, J Kim, M Kuksin, R Levantovsky, L Malle, A Moreira, MD Park, L Pia, E Risson, M Saffern, B Salomé, ME Selvan, MP Spindler, J Tan, V van der Heide, JK Gregory, K Alexandropoulos, N Bhardwaj, BD Brown, B Greenbaum, ZH Gümüş, D Homann, A Horowitz, AO Kamphorst, MA de Lafaille, S Mehandru, M Merad, RM Samstein, M Agrawal, M Aleynick, M Belabed, M Brown, M Casanova-Acebes, J Catalan, M Centa, A Charap, A Chan, ST Chen, J Chung, CC Bozkus, E Cody, F Cossarini, E Dalla, N Fernandez, J Grout, DF Ruan, P Hamon, E Humblin, D Jha, J Kodysh, A Leader, M Lin, K Lindblad, D Lozano-Ojalvo, G Lubitz, A Magen, Z Mahmood, G Martinez-Delgado, J Mateus-Tique, E Meritt, C Moon, J Noel, T ODonnell, M Ota, T Plitt, V Pothula, J Redes, IR Torres, M Roberto, AR Sanchez-Paulete, J Shang, AS Schanoski, M Suprun, M Tran, N Vaninov, CM Wilk, J Aguirre-Ghiso, D Bogunovic, J Cho, J Faith, E Grasset, P Heeger, E Kenigsberg, F Krammer, U Laserson
Immunity 2020
Understanding SARS-CoV-2-Mediated Inflammatory Responses: From Mechanisms to Potential Therapeutic Tools
Y Fu, Y Cheng, Y Wu
Virologica Sinica 2020
The Potential Role of Th17 Immune Responses in Coronavirus Immunopathology and Vaccine-induced Immune Enhancement
PJ Hotez, ME Bottazzi, DB Corry
Microbes and infection / Institut Pasteur 2020
Animal models for emerging coronavirus: progress and new insights
L Yuan, Q Tang, T Cheng, N Xia
Emerging Microbes & Infections 2020
Safety and immunogenicity of a candidate Middle East respiratory syndrome coronavirus viral-vectored vaccine: a dose-escalation, open-label, non-randomised, uncontrolled, phase 1 trial
PM Folegatti, M Bittaye, A Flaxman, FR Lopez, D Bellamy, A Kupke, C Mair, R Makinson, J Sheridan, C Rohde, S Halwe, Y Jeong, YS Park, JO Kim, M Song, A Boyd, N Tran, D Silman, I Poulton, M Datoo, J Marshall, Y Themistocleous, A Lawrie, R Roberts, E Berrie, S Becker, T Lambe, A Hill, K Ewer, S Gilbert
The Lancet Infectious Diseases 2020
Promise and challenges in the development of COVID-19 vaccines
W Chen
Human Vaccines & Immunotherapeutics 2020
Recent Insight into SARS-CoV2 Immunopathology and Rationale for Potential Treatment and Preventive Strategies in COVID-19
S Lega, S Naviglio, S Volpi, A Tommasini
Human vaccines 2020
COVID-19 Vaccines: “Warp Speed” Needs Mind Melds, Not Warped Minds
JP Moore, PJ Klasse, G Silvestri
Journal of virology 2020
An effective CTL peptide vaccine for Ebola Zaire Based on Survivors’ CD8+ targeting of a particular nucleocapsid protein epitope with potential implications for COVID-19 vaccine design
CV Herst, S Burkholz, J Sidney, A Sette, PE Harris, S Massey, T Brasel, E Cunha-Neto, DS Rosa, WC Chao, R Carback, T Hodge, L Wang, S Ciotlos, P Lloyd, R Rubsamen
Vaccine 2020
Immunotherapeutic approaches to curtail COVID-19
H Owji, M Negahdaripour, N Hajighahramani
International Immunopharmacology 2020
COVID-19 in a Severely Immunosuppressed Patient With Life-Threatening Eosinophilic Granulomatosis With Polyangiitis
MA Schramm, N Venhoff, D Wagner, J Thiel, D Huzly, N Craig-Mueller, M Panning, H Hengel, WV Kern, RE Voll
Frontiers in immunology 2020
Serodiagnostics for Severe Acute Respiratory Syndrome–Related Coronavirus 2: A Narrative Review
MP Cheng, CP Yansouni, NE Basta, M Desjardins, S Kanjilal, K Paquette, C Caya, M Semret, C Quach, M Libman, L Mazzola, JA Sacks, S Dittrich, J Papenburg
Annals of internal medicine 2020
Host-Viral Infection Maps Reveal Signatures of Severe COVID-19 Patients
P Bost, A Giladi, Y Liu, Y Bendjelal, G Xu, E David, R Blecher-Gonen, M Cohen, C Medaglia, H Li, A Deczkowska, S Zhang, B Schwikowski, Z Zhang, I Amit
Cell 2020
Immune Phenotyping Based on the Neutrophil-to-Lymphocyte Ratio and IgG Level Predicts Disease Severity and Outcome for Patients With COVID-19
B Zhang, X Zhou, C Zhu, Y Song, F Feng, Y Qiu, J Feng, Q Jia, Q Song, B Zhu, J Wang
Frontiers in Molecular Biosciences 2020
Anti-SARS-CoV-2 hyperimmune plasma workflow
P Annamaria, Q Eugenia, S Paolo
Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis 2020
Potential role of interferons in treating COVID-19 patients
MH Abdolvahab, S Moradi-kalbolandi, M Zarei, D Bose, K Majidzadeh-A, L Farahmand
International Immunopharmacology 2020
Clinical manifestations and evidence of neurological involvement in 2019 novel coronavirus SARS-CoV-2: a systematic review and meta-analysis
L Wang, Y Shen, M Li, H Chuang, Y Ye, H Zhao, H Wang
Journal of Neurology 2020
An adenovirus-vectored COVID-19 vaccine confers protection from SARS-COV-2 challenge in rhesus macaques
L Feng, Q Wang, C Shan, C Yang, Y Feng, J Wu, X Liu, Y Zhou, R Jiang, P Hu, X Liu, F Zhang, P Li, X Niu, Y Liu, X Zheng, J Luo, J Sun, Y Gu, B Liu, Y Xu, C Li, W Pan, J Zhao, C Ke, X Chen, T Xu, N Zhong, S Guan, Z Yuan, L Chen
Nature Communications 2020
Recovery from COVID-19 in a B-cell-depleted multiple sclerosis patient
H Wurm, K Attfield, AK Iversen, R Gold, L Fugger, A Haghikia
Multiple sclerosis (Houndmills, Basingstoke, England) 2020
Nanoparticle Vaccines Based on the Receptor Binding Domain (RBD) and Heptad Repeat (HR) of SARS-CoV-2 Elicit Robust Protective Immune Responses
X Ma, F Zou, F Yu, R Li, Y Yuan, Y Zhang, X Zhang, J Deng, T Chen, Z Song, Y Qiao, Y Zhan, J Liu, J Zhang, X Zhang, Z Peng, Y Li, Y Lin, L Liang, G Wang, Y Chen, Q Chen, T Pan, X He, H Zhang
Immunity 2020
Humoral Responses and Serological Assays in SARS-CoV-2 Infections
Y Galipeau, M Greig, G Liu, M Driedger, MA Langlois
Frontiers in immunology 2020
Antibody response and therapy in COVID-19 patients: what can be learned for vaccine development?
L Lu, H Zhang, M Zhan, J Jiang, H Yin, DJ Dauphars, SY Li, Y Li, YW He
Science China Life Sciences 2020
COVID-19-neutralizing antibodies predict disease severity and survival
WF Garcia-Beltran, EC Lam, MG Astudillo, D Yang, TE Miller, J Feldman, BM Hauser, TM Caradonna, KL Clayton, AD Nitido, MR Murali, G Alter, RC Charles, A Dighe, JA Branda, JK Lennerz, D Lingwood, AG Schmidt, AJ Iafrate, AB Balazs
Cell 2020
SARS-CoV-2 mediated lung inflammatory responses in host: targeting the cytokine storm for therapeutic interventions
P Asrani, I Hassan
Molecular and Cellular Biochemistry 2020
COVID-19: The Emerging Immunopathological Determinants for Recovery or Death
T Ahmad, R Chaudhuri, MC Joshi, A Almatroudi, AH Rahmani, SM Ali
Frontiers in microbiology 2020
Pathophysiology and potential future therapeutic targets using preclinical models of COVID-19
R Kumar, MH Lee, C Mickael, B Kassa, Q Pasha, R Tuder, B Graham
ERJ Open Research 2020
Monocyte activation in systemic Covid-19 infection: Assay and rationale
FO Martinez, TW Combes, F Orsenigo, S Gordon
EBioMedicine 2020
A Thermostable mRNA Vaccine against COVID-19
NN Zhang, XF Li, YQ Deng, H Zhao, YJ Huang, G Yang, WJ Huang, P Gao, C Zhou, RR Zhang, Y Guo, SH Sun, H Fan, SL Zu, Q Chen, Q He, TS Cao, XY Huang, HY Qiu, JH Nie, Y Jiang, HY Yan, Q Ye, X Zhong, XL Xue, ZY Zha, D Zhou, X Yang, YC Wang, B Ying, CF Qin
Cell 2020
COVID-19: Coronavirus Vaccine Development Updates
J Zhao, S Zhao, J Ou, J Zhang, W Lan, W Guan, X Wu, Y Yan, W Zhao, J Wu, J Chodosh, Q Zhang
Frontiers in immunology 2020
Systemic complement activation is associated with respiratory failure in COVID-19 hospitalized patients
JC Holter, SE Pischke, E de Boer, A Lind, S Jenum, AR Holten, K Tonby, A Barratt-Due, M Sokolova, C Schjalm, V Chaban, A Kolderup, T Tran, TT Gjølberg, LG Skeie, L Hesstvedt, V Ormåsen, B Fevang, C Austad, KE Müller, C Fladeby, M Holberg-Petersen, B Halvorsen, F Müller, P Aukrust, S Dudman, T Ueland, JT Andersen, F Lund-Johansen, L Heggelund, AM Dyrhol-Riise, TE Mollnes
Proceedings of the National Academy of Sciences 2020
Therapeutic modalities and novel approaches in regenerative medicine for COVID-19
R Ramezankhani, R Solhi, A Memarnejadian, F Nami, SM Hashemian, T Tricot, M Vosough, C Verfaillie
International Journal of Antimicrobial Agents 2020
Dissecting antibody-mediated protection against SARS-CoV-2
T Zohar, G Alter
Nature Reviews Immunology 2020
Does SARS-CoV-2 Trigger Stress-Induced Autoimmunity by Molecular Mimicry? A Hypothesis
F Cappello, AM Gammazza, F Dieli, EC de Macario, AJ Macario
Journal of Clinical Medicine 2020
Blood Banking and Transfusion Medicine Challenges During the COVID-19 Pandemic
A Ngo, D Masel, C Cahill, N Blumberg, MA Refaai
Clinics in Laboratory Medicine 2020
Cellular and Molecular Pathways of COVID-19 and Potential Points of Therapeutic Intervention
JP Hussman
Frontiers in pharmacology 2020
Convalescent Plasma: The Relay Baton in the Race for Coronavirus Disease 2019 Treatment
J Ouyang, S Isnard, J Lin, B Fombuena, X Peng, JP Routy, Y Chen
Frontiers in immunology 2020
Convalescent Plasma against COVID-19: A Broad-Spectrum Therapeutic Approach for Emerging Infectious Diseases
M Thijssen, T Devos, HS Ejtahed, S Amini-Bavil-Olyaee, AA Pourfathollah, MR Pourkarim
Microorganisms 2020
Antibody-dependent enhancement and COVID-19: Moving toward acquittal
EJ Yager
Clinical Immunology 2020
The role of host genetics in the immune response to SARS‐CoV‐2 and COVID‐19 susceptibility and severity
IG Ovsyannikova, IH Haralambieva, SN Crooke, GA Poland, RB Kennedy
Immunological Reviews 2020
COVID-19: Immunology and treatment options
S Felsenstein, JA Herbert, PS McNamara, CM Hedrich
Clinical Immunology 2020
In vivo expressed biologics for infectious disease prophylaxis: rapid delivery of DNA-based antiviral antibodies
CD Andrews, Y Huang, DD Ho, RA Liberatore
Emerging Microbes & Infections 2020
Immunological considerations for COVID-19 vaccine strategies
M Jeyanathan, S Afkhami, F Smaill, MS Miller, BD Lichty, Z Xing
Nature Reviews Immunology 2020
Pandemic Preparedness: Developing Vaccines and Therapeutic Antibodies For COVID-19
GD Sempowski, KO Saunders, P Acharya, KJ Wiehe, BF Haynes
Cell 2020
Convalescent plasma to treat critically ill patients with COVID-19: framing the need for randomised clinical trials
M Shankar-Hari, L Estcourt, H Harvala, D Roberts, DK Menon, M Shankar-Hari, L Estcourt, H Harvala, D Roberts, DK Menon
Critical Care 2020
Is Cross-Reactive Immunity Triggering COVID-19 Immunopathogenesis?
A Beretta, M Cranage, D Zipeto
Frontiers in immunology 2020
Vaccination against SARS-CoV-2 and disease enhancement – knowns and unknowns
RM Zellweger, TA Wartel, F Marks, M Song, JH Kim
Expert Review of Vaccines 2020
New Insights of Emerging SARS-CoV-2: Epidemiology, Etiology, Clinical Features, Clinical Treatment, and Prevention
G Guo, L Ye, K Pan, Y Chen, D Xing, K Yan, Z Chen, N Ding, W Li, H Huang, L Zhang, X Li, X Xue
Frontiers in Cell and Developmental Biology 2020
Biomaterials-Based Opportunities to Engineer the Pulmonary Host Immune Response in COVID-19
BM Jarai, Z Stillman, K Bomb, AM Kloxin, CA Fromen
ACS Biomaterials Science & Engineering 2020
Repurposing Drugs, Ongoing Vaccine, and New Therapeutic Development Initiatives Against COVID-19
RP Saha, AR Sharma, MK Singh, S Samanta, S Bhakta, S Mandal, M Bhattacharya, SS Lee, C Chakraborty
Frontiers in pharmacology 2020
Antibodies to SARS-CoV-2 and their potential for therapeutic passive immunization
PJ Klasse, JP Moore
eLife 2020
Coronavirus disease 2019 (COVID‐19): An overview of the immunopathology, serological diagnosis and management
AU Anka, MI Tahir, SD Abubakar, M Alsabbagh, Z Zian, H Hamedifar, A Sabzevari, G Azizi
Scandinavian Journal of Immunology 2020
Severe COVID-19: what have we learned with the immunopathogenesis?
B Bordallo, M Bellas, AF Cortez, M Vieira, M Pinheiro
2020
SARS-CoV-2 Treatment Approaches: Numerous Options, No Certainty for a Versatile Virus
S Iacob, DG Iacob
Frontiers in pharmacology 2020
The four horsemen of a viral Apocalypse: The pathogenesis of SARS-CoV-2 infection (COVID-19)
P Domingo, I Mur, V Pomar, H Corominas, J Casademont, N de Benito
EBioMedicine 2020
Immune Response to COVID-19: Can We Benefit from the SARS-CoV and MERS-CoV Pandemic Experience?
E Sinderewicz, W Czelejewska, K Jezierska-Wozniak, J Staszkiewicz-Chodor, W Maksymowicz
Pathogens 2020
COVID‐19 and immunological regulations – from basic and translational aspects to clinical implications
MP Schön, C Berking, T Biedermann, T Buhl, L Erpenbeck, K Eyerich, S Eyerich, K Ghoreschi, M Goebeler, RJ Ludwig, K Schäkel, B Schilling, C Schlapbach, G Stary, E Stebut, K Steinbrink
Journal der Deutschen Dermatologischen Gesellschaft 2020
COVID-19 Pandemic: Epidemiology, Etiology, Conventional and Non-Conventional Therapies
A Rauf, T Abu-Izneid, A Olatunde, AA Khalil, FA Alhumaydhi, T Tufail, MA Shariati, M Rebezov, ZM Almarhoon, YN Mabkhot, A Alsayari, KR Rengasamy
International journal of environmental research and public health 2020
Severe acute respiratory syndrome‐coronavirus‐2 spike (S) protein based vaccine candidates: State of the art and future prospects
A Arashkia, S Jalilvand, N Mohajel, A Afchangi, K Azadmanesh, M SalehiVaziri, M Fazlalipour, MH Pouriayevali, T Jalali, SD Nasab, F Roohvand, Z Shoja
Reviews in Medical Virology 2020
The underpinning biology relating to multiple sclerosis disease modifying treatments during the COVID-19 pandemic
D Baker, S Amor, AS Kang, K Schmierer, G Giovannoni
Multiple Sclerosis and Related Disorders 2020
Human post‐infection serological response to the spike and nucleocapsid proteins of SARS‐CoV‐2
C Xiao, S Ling, M Qiu, Z Deng, L Chen, A Zhu, Y Chen, Y Liu, X Lin, F Lin, Q Wu, L Shen, F Ye, X Liu, Y Li, J Zhao, Z Yang, BJ Cowling, R Webby, M Zanin, SS Wong
Influenza and Other Respiratory Viruses 2020
A Single-Dose Intranasal ChAd Vaccine Protects Upper and Lower Respiratory Tracts against SARS-CoV-2
AO Hassan, NM Kafai, IP Dmitriev, JM Fox, BK Smith, IB Harvey, RE Chen, ES Winkler, AW Wessel, JB Case, E Kashentseva, BT McCune, AL Bailey, H Zhao, LA VanBlargan, YN Dai, M Ma, LJ Adams, S Shrihari, JE Danis, LE Gralinski, YJ Hou, A Schäfer, AS Kim, SP Keeler, D Weiskopf, RS Baric, MJ Holtzman, DH Fremont, DT Curiel, MS Diamond
Cell 2020
STAT2 signaling restricts viral dissemination but drives severe pneumonia in SARS-CoV-2 infected hamsters
R Boudewijns, HJ Thibaut, SJ Kaptein, R Li, V Vergote, L Seldeslachts, JV Weyenbergh, CD Keyzer, L Bervoets, S Sharma, L Liesenborghs, J Ma, S Jansen, DV Looveren, T Vercruysse, X Wang, D Jochmans, E Martens, K Roose, DD Vlieger, B Schepens, TV Buyten, S Jacobs, Y Liu, J Martí-Carreras, B Vanmechelen, T Wawina-Bokalanga, L Delang, J Rocha-Pereira, L Coelmont, W Chiu, P Leyssen, E Heylen, D Schols, L Wang, L Close, J Matthijnssens, MV Ranst, V Compernolle, G Schramm, KV Laere, X Saelens, N Callewaert, G Opdenakker, P Maes, B Weynand, C Cawthorne, GV Velde, Z Wang, J Neyts, K Dallmeier
Nature Communications 2020
Principles Learned from the International Race to Develop a Safe and Effective COVID-19 Vaccine
AH Thames, KL Wolniak, SI Stupp, MC Jewett
ACS Central Science 2020
Treatment of COVID-19 with remdesivir in the absence of humoral immunity: a case report
MS Buckland, JB Galloway, CN Fhogartaigh, L Meredith, NM Provine, S Bloor, A Ogbe, WM Zelek, A Smielewska, A Yakovleva, T Mann, L Bergamaschi, L Turner, F Mescia, EJ Toonen, CP Hackstein, HD Akther, VA Vieira, L Ceron-Gutierrez, J Periselneris, S Kiani-Alikhan, S Grigoriadou, D Vaghela, SE Lear, ME Török, WL Hamilton, J Stockton, J Quick, P Nelson, M Hunter, TI Coulter, L Devlin, JR Bradley, KG Smith, WH Ouwehand, L Estcourt, H Harvala, DJ Roberts, IB Wilkinson, N Screaton, N Loman, R Doffinger, PA Lyons, BP Morgan, IG Goodfellow, P Klenerman, PJ Lehner, NJ Matheson, JE Thaventhiran
Nature Communications 2020
Significant Unresolved Questions and Opportunities for Bioengineering in Understanding and Treating COVID-19 Disease Progression
J Shirazi, MJ Donzanti, KM Nelson, R Zurakowski, CA Fromen, JP Gleghorn
Cellular and Molecular Bioengineering 2020
Artificial intelligence predicts the immunogenic landscape of SARS-CoV-2 leading to universal blueprints for vaccine designs
B Malone, B Simovski, C Moliné, J Cheng, M Gheorghe, H Fontenelle, I Vardaxis, S Tennøe, JA Malmberg, R Stratford, T Clancy
Scientific Reports 2020
A cross-reactive human IgA monoclonal antibody blocks SARS-CoV-2 spike-ACE2 interaction
M Ejemel, Q Li, S Hou, ZA Schiller, JA Tree, A Wallace, A Amcheslavsky, NK Yilmaz, KR Buttigieg, MJ Elmore, K Godwin, N Coombes, JR Toomey, R Schneider, AS Ramchetty, BJ Close, DY Chen, HL Conway, M Saeed, C Ganesa, MW Carroll, LA Cavacini, MS Klempner, CA Schiffer, Y Wang
Nature Communications 2020
Prospect of SARS-CoV-2 spike protein: Potential role in vaccine and therapeutic development
SK Samrat, AM Tharappel, Z Li, H Li
Virus Research 2020
As Plain as the Nose on Your Face: The Case for A Nasal (Mucosal) Route of Vaccine Administration for Covid-19 Disease Prevention
CR Travis
Frontiers in immunology 2020
Antibody Response to Severe Acute Respiratory Syndrome‐ Corona Virus 2, Diagnostic and Therapeutic Implications
Y Ishay, A Kessler, A Schwarts, Y Ilan
Hepatology Communications 2020
Learning from the past: development of safe and effective COVID-19 vaccines
S Su, L Du, S Jiang
Nature Reviews Microbiology 2020
On the genetics and immunopathogenesis of COVID-19
CO Jacob
Clinical Immunology 2020
Dysregulation of type I interferon responses in COVID-19
D Acharya, GQ Liu, MU Gack
Nature Reviews Immunology 2020
COVID‐19 und Immunregulation – von grundlegenden und translationalen Aspekten zu klinischen Implikationen
MP Schön, C Berking, T Biedermann, T Buhl, L Erpenbeck, K Eyerich, S Eyerich, K Ghoreschi, M Goebeler, RJ Ludwig, K Schäkel, B Schilling, C Schlapbach, G Stary, E Stebut, K Steinbrink
Journal der Deutschen Dermatologischen Gesellschaft 2020
Cytokine storm induced by SARS-CoV-2
P Song, W Li, J Xie, Y Hou, C You
Clinica chimica acta; international journal of clinical chemistry 2020
Clinical predictors of donor antibody titre and correlation with recipient antibody response in a COVID‐19 convalescent plasma clinical trial
ML Madariaga, JJ Guthmiller, S Schrantz, MO Jansen, C Christensen, M Kumar, M Prochaska, G Wool, A DurkinCelauro, WH Oh, L Trockman, J Vigneswaran, R Keskey, DG Shaw, H Dugan, NY Zheng, M Cobb, H Utset, J Wang, O Stovicek, C Bethel, S Matushek, M Giurcanu, KG Beavis, D Sabato, D Meltzer, MK Ferguson, JP Kress, K Shanmugarajah, JB Matthews, JF Fung, PC Wilson, JC Alverdy, JS Donington
Journal of Internal Medicine 2020
Active Therapy with Passive Immunotherapy May Be Effective in the Fight against COVID‐19
CJ Morabito, B Gangadharan
Clinical and Translational Science 2020
The role of SARS‐CoV ‐2 antibodies in COVID ‐19: Healing in most, harm at times
MA French, Y Moodley
Respirology (Carlton, Vic.) 2020
SARS-CoV-2/COVID-19: Evolving Reality, Global Response, Knowledge Gaps, and Opportunities
MF Osuchowski, F Aletti, JM Cavaillon, SB Flohé, EJ Giamarellos-Bourboulis, M Huber-Lang, B Relja, T Skirecki, A Szabó, M Maegele
Shock 2020
ADE and hyperinflammation in SARS-CoV2 infection- comparison with dengue hemorrhagic fever and feline infectious peritonitis
M Cloutier, M Nandi, AU Ihsan, HA Chamard, S Ilangumaran, S Ramanathan
Cytokine 2020
Consensus Summary Report for CEPI/BC March 12-13, 2020 Meeting: Assessment of Risk of Disease Enhancement with COVID-19 Vaccines
PH Lambert, DM Ambrosino, SR Andersen, RS Baric, SB Black, RT Chen, CL Dekker, AM Didierlaurent, BS Graham, SD Martin, DC Molrine, S Perlman, PA Picard-Fraser, AJ Pollard, C Qin, K Subbarao, JP Cramer
Vaccine 2020
Viral targets for vaccines against COVID-19
L Dai, GF Gao
Nature Reviews Immunology 2020
Sustained Responses of Neutralizing Antibodies Against Middle East Respiratory Syndrome Coronavirus (MERS-CoV) in Recovered Patients and Their Therapeutic Applicability
YS Kim, A Aigerim, U Park, Y Kim, H Park, JY Rhee, JP Choi, WB Park, SW Park, Y Kim, DG Lim, JY Choi, YK Jeon, JS Yang, JY Lee, HS Shin, NH Cho
Clinical Infectious Diseases 2020
What are the roles of antibodies versus a durable, high quality T-cell response in protective immunity against SARS-CoV-2?
M Hellerstein
2020
Host-pathogen interaction in COVID-19: Pathogenesis, potential therapeutics and vaccination strategies
PM Varghese, AG Tsolaki, H Yasmin, A Shastri, J Ferluga, M Vatish, T Madan, U Kishore
Immunobiology 2020
Convalescent plasma therapy for coronavirus infection: experience from MERS and application in COVID-19
JA Al-Tawfiq, Y Arabi
Human Vaccines & Immunotherapeutics 2020
Immunity, endothelial injury and complement-induced coagulopathy in COVID-19
L Perico, A Benigni, F Casiraghi, LF Ng, L Renia, G Remuzzi
Nature Reviews Nephrology 2020
Severe COVID-19 and aging: are monocytes the key?
Pence BD
GeroScience 2020
ACE2 at the centre of COVID-19 from paucisymptomatic infections to severe pneumonia
Rivellese F, Prediletto E
Autoimmunity Reviews 2020
A Testimony of the Surgent SARS-CoV-2 in the Immunological Panorama of the Human Host
Minakshi R, Jan AT, Rahman S, Kim J
Frontiers in Cellular and Infection Microbiology 2020
COVID-19 and lung cancer: risks, mechanisms and treatment interactions.
Addeo A, Obeid M, Friedlaender A
Journal for ImmunoTherapy of Cancer 2020
Next-Generation Sequencing of T and B Cell Receptor Repertoires from COVID-19 Patients Showed Signatures Associated with Severity of Disease.
Schultheiß C, Paschold L, Simnica D, Mohme M, Willscher E, von Wenserski L, Scholz R, Wieters I, Dahlke C, Tolosa E, Sedding DG, Ciesek S, Addo M, Binder M
Immunity 2020
Cancer and COVID-19: Unmasking their ties.
Addeo A, Friedlaender A
Cancer Treatment Reviews 2020
Mechanisms of SARS-CoV-2 Transmission and Pathogenesis.
Harrison AG, Lin T, Wang P
Trends in Immunology 2020
Fostamatinib Inhibits Neutrophils Extracellular Traps Induced by COVID-19 Patient Plasma: A Potential Therapeutic
Strich JR, Ramos-Benitez MJ, Randazzo D, Stein SR, Babyak A, Davey RT, Suffredini AF, Childs RW, Chertow DS
The Journal of Infectious Diseases 2020
SARS-CoV-2 immunity: review and applications to phase 3 vaccine candidates.
Poland GA, Ovsyannikova IG, Kennedy RB
2020
Prospects for mucosal vaccine: shutting the door on SARS-CoV-2.
Mudgal R, Nehul S, Tomar S
Human Vaccines & Immunotherapeutics 2020
Risiken und Chancen von Immuntherapien in Zeiten der Coronavirus-2019-Pandemie
Pawlitzki M, Zettl UK, Ruck T, Rolfes L, Hartung HP, Meuth SG
2020
High neutralizing antibody titer in intensive care unit patients with COVID-19
Liu L, To KK, Chan KH, Wong YC, Zhou R, Kwan KY, Fong CH, Chen LL, Choi CY, Lu L, Tsang OT, Leung WS, To WK, Hung IF, Yuen KY, Chen Z
Emerging Microbes & Infections 2020
Rekonvaleszentenplasma zur Behandlung von schwerem COVID-19: Rationale und Design einer randomisierten, offenen klinischen Studie von Rekonvaleszentenplasma verglichen mit bestmöglicher supportiver Behandlung (CAPSID-Studie)
Körper S, Jahrsdörfer B, Appl T, Klüter H, Seifried E, Schrezenmeier H
2020
Harnessing Recent Advances in Synthetic DNA and Electroporation Technologies for Rapid Vaccine Development Against COVID-19 and Other Emerging Infectious Diseases
Xu Z, Patel A, Tursi NJ, Zhu X, Muthumani K, Kulp DW, Weiner DB
2020
Immunoregulation with mTOR inhibitors to prevent COVID-19 severity: A novel intervention strategy beyond vaccines and specific antiviral medicines.
Zheng Y, Li R, Liu S
Journal of Medical Virology 2020
Immune Alterations in a Patient with SARS-CoV-2-Related Acute Respiratory Distress Syndrome.
Bouadma L, Wiedemann A, Patrier J, Surénaud M, Wicky PH, Foucat E, Diehl JL, Hejblum BP, Sinnah F, de Montmollin E, Lacabaratz C, Thiébaut R, Timsit JF, Lévy Y
Journal of Clinical Immunology 2020
Fruitful Neutralizing Antibody Pipeline Brings Hope To Defeat SARS-Cov-2.
Renn A, Fu Y, Hu X, Hall MD, Simeonov A
Trends in Pharmacological Sciences 2020
Anti-IL6R role in treatment of COVID-19-related ARDS
Buonaguro FM, Puzanov I, Ascierto PA
Journal of Translational Medicine 2020
Covid‐19 and dengue: Double punches for dengue‐endemic countries in Asia
Harapan H, Ryan M, Yohan B, Abidin RS, Nainu F, Rakib A, Jahan I, Emran TB, Ullah I, Panta K, Dhama K, Sasmono RT
Reviews in Medical Virology 2020
Susceptibility of the Elderly to SARS-CoV-2 Infection: ACE-2 Overexpression, Shedding, and Antibody-dependent Enhancement (ADE)
Peron JP, Nakaya H
Clinics 2020
Employing drug delivery strategies to create safe and effective pharmaceuticals for COVID‐19
McHugh KJ
Bioengineering & Translational Medicine 2020
Progress and Concept for COVID‐19 Vaccine Development
Wu S
Biotechnology Journal 2020
Distinct features of SARS-CoV-2-specific IgA response in COVID-19 patients
Yu HQ, Sun BQ, Fang ZF, Zhao JC, Liu XY, Li YM, Sun XZ, Liang HF, Zhong B, Huang ZF, Zheng PY, Tian LF, Qu HQ, Liu DC, Wang EY, Xiao XJ, Li SY, Ye F, Guan L, Hu DS, Hakonarson H, Liu ZG, Zhong NS
European Respiratory Journal 2020
Balancing Expediency and Scientific Rigor in Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Development
Graepel KW, Kochhar S, Clayton EW, Edwards KE
The Journal of Infectious Diseases 2020
ChAdOx1 nCoV-19 vaccination prevents SARS-CoV-2 pneumonia in rhesus macaques
van Doremalen N, Lambe T, Spencer A, Belij-Rammerstorfer S, Purushotham JN, Port JR, Avanzato V, Bushmaker T, Flaxman A, Ulaszewska M, Feldmann F, Allen ER, Sharpe H, Schulz J, Holbrook M, Okumura A, Meade-White K, Pérez-Pérez L, Bissett C, Gilbride C, Williamson BN, Rosenke R, Long D, Ishwarbhai A, Kailath R, Rose L, Morris S, Powers C, Lovaglio J, Hanley PW, Scott D, Saturday G, de Wit E, Gilbert SC, Munster VJ
2020
Lack of cross-neutralization by SARS patient sera towards SARS-CoV-2
Anderson DE, Tan CW, Chia WN, Young BE, Linster M, Low JH, Tan YJ, Chen MI, Smith GJ, Leo YS, Lye DC, Wang LF
Emerging Microbes & Infections 2020
Different longitudinal patterns of nucleic acid and serology testing results based on disease severity of COVID-19 patients
Yongchen Z, Shen H, Wang X, Shi X, Li Y, Yan J, Chen Y, Gu B
Emerging Microbes & Infections 2020
Humoral Immune Responses in COVID-19 Patients: A Window on the State of the Art
Siracusano G, Pastori C, Lopalco L
Frontiers in immunology 2020
DNA vaccine protection against SARS-CoV-2 in rhesus macaques
Yu J, Tostanoski LH, Peter L, Mercado NB, McMahan K, Mahrokhian SH, Nkolola JP, Liu J, Li Z, Chandrashekar A, Martinez DR, Loos C, Atyeo C, Fischinger S, Burke JS, Slein MD, Chen Y, Zuiani A, Lelis FJ, Travers M, Habibi S, Pessaint L, Van Ry A, Blade K, Brown R, Cook A, Finneyfrock B, Dodson A, Teow E, Velasco J, Zahn R, Wegmann F, Bondzie EA, Dagotto G, Gebre MS, He X, Jacob-Dolan C, Kirilova M, Kordana N, Lin Z, Maxfield LF, Nampanya F, Nityanandam R, Ventura JD, Wan H, Cai Y, Chen B, Schmidt AG, Wesemann DR, Baric RS, Alter G, Andersen H, Lewis MG, Barouch DH
Science (New York, N.Y.) 2020
Coronaviruses pandemics: Can neutralizing antibodies help?
Tong PB, Lin LY, Tran TH
Life Sciences 2020
Current global vaccine and drug efforts against COVID-19: Pros and cons of bypassing animal trials
Deb B, Shah H, Goel S
Journal of Biosciences 2020
Four point-of-care lateral flow immunoassays for diagnosis of COVID-19 and for assessing dynamics of antibody responses to SARS-CoV-2
Wu JL, Tseng WP, Lin CH, Lee TF, Chung MY, Huang CH, Chen SY, Hsueh PR, Chen SC
Journal of Infection 2020
Recent Understandings Toward Coronavirus Disease 2019 (COVID-19): From Bench to Bedside
Yu J, Chai P, Ge S, Fan X
Frontiers in Cell and Developmental Biology 2020
Immunoinformatics characterization of SARS-CoV-2 spike glycoprotein for prioritization of epitope based multivalent peptide vaccine
Ismail S, Ahmad S, Azam SS
Journal of Molecular Liquids 2020
Dengue Fever, COVID‐19 (SARS‐CoV‐2), and Antibody‐Dependent Enhancement (ADE): A Perspective
Ulrich H, Pillat MM, Tárnok A
Cytometry Part A 2020
Considerations on biologicals for patients with allergic disease in times of the COVID‐19 pandemic: An EAACI statement
Vultaggio A, Agache I, Akdis CA, Akdis M, Bavbek S, Bossios A, Bousquet J, Boyman O, Chaker AM, Chan S, Chatzipetrou A, Feleszko W, Firinu D, Jutel M, Kauppi P, Klimek L, Kolios A, Kothari A, Kowalski ML, Matucci A, Palomares O, Pfaar O, Rogala B, Untersmayr E, Eiwegger T
Allergy 2020
COVID-19 Diagnostics, Tools, and Prevention
Allam M, Cai S, Ganesh S, Venkatesan M, Doodhwala S, Song Z, Hu T, Kumar A, Heit J, Coskun AF
Diagnostics 2020
Childhood Multisystem Inflammatory Syndrome — A New Challenge in the Pandemic
Levin M
The New England journal of medicine 2020
Dysregulated adaptive immune response contributes to severe COVID-19
Yu K, He J, Wu Y, Xie B, Liu X, Wei B, Zhou H, Lin B, Zuo Z, Wen W, Xu W, Zou B, Wei L, Huang X, Zhou P
Cell Research 2020
The dynamic changes of serum IgM and IgG against SARS‐CoV‐2 in patients with COVID‐19
Zhou W, Xu X, Chang Z, Wang H, Zhong X, Tong X, Liu T, Li Y
Journal of Medical Virology 2020
SARS-CoV2 vaccines: Slow is fast
Green DR
Science Advances 2020
What Would Jenner and Pasteur Have Done About COVID-19 Coronavirus? The Urges of a Vaccinologist
Palatnik-de-Sousa CB
Frontiers in immunology 2020
Can Nuclear Imaging of Activated Macrophages with Folic Acid-Based Radiotracers Serve as a Prognostic Means to Identify COVID-19 Patients at Risk?
Müller C, Schibli R, Maurer B
Pharmaceuticals 2020
Rabies virus-based COVID-19 vaccine CORAVAX™ induces high levels of neutralizing antibodies against SARS-CoV-2
Kurup D, Wirblich C, Ramage H, Schnell MJ
npj Vaccines 2020
Change of Antigenic Determinants of SARS-CoV-2 Virus S-Protein as a Possible Cause of Antibody-Dependent Enhancement of Virus Infection and Cytokine Storm
Nechipurenko YD, Anashkina AA, Matveeva OV
Biophysics 2020
Coronavirus-2019 Disease (COVID-19) in Children
Ovali F
2020
Informed consent disclosure to vaccine trial subjects of risk of COVID‐19 vaccines worsening clinical disease
Cardozo T, Veazey R
International Journal of Clinical Practice 2020
Multisystem Inflammatory Syndrome in Children Related to COVID-19: the First Case in Korea
Kim H, Shim JY, Ko JH, Yang A, Shim JW, Kim DS, Jung HL, Kwak JH, Sol IS
Journal of Korean Medical Science 2020
Immune responses to SARS-CoV-2 infection in hospitalized pediatric and adult patients
Pierce CA, Preston-Hurlburt P, Dai Y, Aschner CB, Cheshenko N, Galen B, Garforth SJ, Herrera NG, Jangra RK, Morano NC, Orner E, Sy S, Chandran K, Dziura J, Almo SC, Ring A, Keller MJ, Herold KC, Herold BC
Science Translational Medicine 2020
Characterization of neutralizing antibody with prophylactic and therapeutic efficacy against SARS-CoV-2 in rhesus monkeys
Wang S, Peng Y, Wang R, Jiao S, Wang M, Huang W, Shan C, Jiang W, Li Z, Gu C, Chen B, Hu X, Yao Y, Min J, Zhang H, Chen Y, Gao G, Tang P, Li G, Wang A, Wang L, Zhang J, Chen S, Gui X, Yuan Z, Liu D
Nature Communications 2020
Drawing Comparisons between SARS-CoV-2 and the Animal Coronaviruses
Ghosh S, Malik YS
Microorganisms 2020
How to Survive COVID‐19 Even If the Vaccine Fails
Branch AD
Hepatology Communications 2020
Case Report: Convalescent Plasma, a Targeted Therapy for Patients with CVID and Severe COVID-19
Van Damme KF, Tavernier S, Van Roy N, De Leeuw E, Declercq J, Bosteels C, Maes B, De Bruyne M, Bogaert D, Bosteels V, Hoste L, Naesens L, Maes P, Grifoni A, Weiskopf D, Sette A, Depuydt P, Van Braeckel E, Haerynck F, Lambrecht BN
Frontiers in immunology 2020
Antibody responses in COVID-19 patients
Liu S, Lu S
Journal of Biomedical Research 2020
Potential roles of mitochondrial cofactors in the adjuvant mitigation of proinflammatory acute infections, as in the case of sepsis and COVID-19 pneumonia
Pagano G, Manfredi C, Pallardó FV, Lyakhovich A, Tiano L, Trifuoggi M
Inflammation Research 2020
Product of natural evolution (SARS, MERS, and SARS-CoV-2); deadly diseases, from SARS to SARS-CoV-2
Shahrajabian MH, Sun W, Cheng Q
Human Vaccines & Immunotherapeutics 2020
ChAdOx1 nCoV-19 vaccine prevents SARS-CoV-2 pneumonia in rhesus macaques
van Doremalen N, Lambe T, Spencer A, Belij-Rammerstorfer S, Purushotham JN, Port JR, Avanzato VA, Bushmaker T, Flaxman A, Ulaszewska M, Feldmann F, Allen ER, Sharpe H, Schulz J, Holbrook M, Okumura A, Meade-White K, Pérez-Pérez L, Edwards NJ, Wright D, Bissett C, Gilbride C, Williamson BN, Rosenke R, Long D, Ishwarbhai A, Kailath R, Rose L, Morris S, Powers C, Lovaglio J, Hanley PW, Scott D, Saturday G, de Wit E, Gilbert SC, Munster VJ
Nature 2020
COVID-19 - Recent advancements in identifying novel vaccine candidates and current status of upcoming SARS-CoV-2 vaccines
Iqbal Yatoo M, Hamid Z, Parray OR, Wani AH, Ul Haq A, Saxena A, Patel SK, Pathak M, Tiwari R, Malik YS, Sah R, Rabaan AA, Rodriguez Morales AJ, Dhama K
Human Vaccines & Immunotherapeutics 2020
Coronavirus disease 2019 (COVID-19) in domestic animals and wildlife: advances and prospects in the development of animal models for vaccine and therapeutic research
Sharun K, Tiwari R, Patel SK, Karthik K, Iqbal Yatoo M, Malik YS, Singh KP, Panwar PK, Harapan H, Singh RK, Dhama K
Human Vaccines & Immunotherapeutics 2020
Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study.
To KK, Tsang OT, Leung WS, Tam AR, Wu TC, Lung DC, Yip CC, Cai JP, Chan JM, Chik TS, Lau DP, Choi CY, Chen LL, Chan WM, Chan KH, Ip JD, Ng AC, Poon RW, Luo CT, Cheng VC, Chan JF, Hung IF, Chen Z, Chen H, Yuen KY
The Lancet Infectious Diseases 2020
Perspectives on therapeutic neutralizing antibodies against the Novel Coronavirus SARS-CoV-2.
Zhou G, Zhao Q
International journal of biological sciences 2020
Progress and Prospects on Vaccine Development against SARS-CoV-2.
Zhang J, Zeng H, Gu J, Li H, Zheng L, Zou Q
Human vaccines 2020
Hyperglycemia, hydroxychloroquine, and the COVID-19 pandemic.
Brufsky A
Journal of Medical Virology 2020
Therapeutic opportunities to manage COVID-19/SARS-CoV-2 infection: Present and future.
Shetty R, Ghosh A, Honavar SG, Khamar P, Sethu S
Indian journal of ophthalmology 2020
A strategy targeting monocyte-macrophage differentiation to avoid pulmonary complications in SARS-Cov2 infection.
Gómez-Rial J, Martinón-Torres F
Clinical Immunology 2020
COVID-19 diagnosis and management: a comprehensive review.
Pascarella G, Strumia A, Piliego C, Bruno F, Del Buono R, Costa F, Scarlata S, Agrò FE
Journal of Internal Medicine 2020
COVID-19 Convalescent Plasma: Now Is the Time for Better Science.
Dzik S
Transfusion Medicine Reviews 2020
Current studies of convalescent plasma therapy for COVID-19 may underestimate risk of antibody-dependent enhancement.
Fleming AB, Raabe V
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2020
COVID-19 in Newborns and Infants-Low Risk of Severe Disease: Silver Lining or Dark Cloud?
Rawat M, Chandrasekharan P, Hicar MD, Lakshminrusimha S
American journal of perinatology 2020
Immunoglobulins in the treatment of COVID-19 infection: Proceed with caution!
Nguyen AA, Habiballah SB, Platt CD, Geha RS, Chou JS, McDonald DR
Clinical Immunology 2020
The Rationale for Potential Pharmacotherapy of COVID-19.
Saber-Ayad M, Saleh MA, Abu-Gharbieh E
Pharmaceuticals (Basel, Switzerland) 2020
COVID-19 vaccines: Knowing the unknown.
Lv H, Wu NC, Mok CKP
European Journal of Immunology 2020
From SARS-CoV to SARS-CoV-2: safety and broad-spectrum are important for coronavirus vaccine development.
Ma C, Su S, Wang J, Wei L, Du L, Jiang S
Microbes and Infection 2020
Prevention and treatment of COVID-19 disease by controlled modulation of innate immunity.
Schijns V, Lavelle EC
European Journal of Immunology 2020
COVID-19: are neutralizing antibodies neutralizing enough?
Kadkhoda K
Transfusion 2020
Mild Course of COVID-19 and Spontaneous Virus Clearance in a Patient With Depleted Peripheral Blood B Cells Due to Rituximab Treatment.
Fallet B, Kyburz D, Walker UA
Arthritis & Rheumatism 2020
A Comprehensive Updated Review on SARS-CoV-2 and COVID-19.
Ren YR, Golding A, Sorbello A, Ji P, Chen J, Saluja B, Witzmann K, Arya V, Reynolds KS, Choi SY, Nikolov NP, Sahajwalla C
Journal of clinical pharmacology 2020
SARS-CoV-2 and COVID-19: A genetic, epidemiological, and evolutionary perspective.
Sironi M, Hasnain SE, Rosenthal B, Phan T, Luciani F, Shaw MA, Sallum MA, Mirhashemi ME, Morand S, González-Candelas F
Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases 2020
Cytokine storm in COVID-19: pathogenesis and overview of anti-inflammatory agents used in treatment.
Soy M, Keser G, Atagündüz P, Tabak F, Atagündüz I, Kayhan S
Clinical Rheumatology 2020
Clinical Characteristics of 58 Children With a Pediatric Inflammatory Multisystem Syndrome Temporally Associated With SARS-CoV-2.
Whittaker E, Bamford A, Kenny J, Kaforou M, Jones CE, Shah P, Ramnarayan P, Fraisse A, Miller O, Davies P, Kucera F, Brierley J, McDougall M, Carter M, Tremoulet A, Shimizu C, Herberg J, Burns JC, Lyall H, Levin M
Journal of the American Medical Association 2020
mRNA Vaccines: Possible Tools to Combat SARS-CoV-2.
Yi C, Yi Y, Li J
Virologica Sinica 2020
Monoclonal antibody as a potential anti-COVID-19.
Jahanshahlu L, Rezaei N
Biomedicine & Pharmacotherapy 2020
Autoimmunity to ACE2 as a possible cause of tissue inflammation in Covid-19.
Townsend A
Medical Hypotheses 2020
Role of Monocytes/Macrophages in Covid-19 Pathogenesis: Implications for Therapy.
Gómez-Rial J, Rivero-Calle I, Salas A, Martinón-Torres F
Infection and drug resistance 2020
Current Status of Laboratory Diagnosis for COVID-19: A Narrative Review.
Russo A, Minichini C, Starace M, Astorri R, Calò F, Coppola N
Infection and drug resistance 2020
Challenges and prospects of COVID-19 vaccine development based on the progress made in SARS and MERS vaccine development.
Begum J, Mir NA, Dev K, Buyamayum B, Wani MY, Raza M
Transboundary and Emerging Diseases 2020
SARS-CoV2 vertical transmission with adverse effects on the newborn revealed through integrated immunohistochemical, electron microscopy and molecular analyses of Placenta.
Facchetti F, Bugatti M, Drera E, Tripodo C, Sartori E, Cancila V, Papaccio M, Castellani R, Casola S, Boniotti MB, Cavadini P, Lavazza A
EBioMedicine 2020
Ramping up of SARS CoV-2 testing for the diagnosis of COVID-19 to better manage the next phase of pandemic and reduce the mortality in India.
Natesan S, Bhatia R, Sundararajan A, Dhama K, Malik YS, Vora K
VirusDisease 2020
CT Findings in a Novel Coronavirus Disease (COVID-19) Pneumonia at Initial Presentation.
Xiang C, Lu J, Zhou J, Guan L, Yang C, Chai C
BioMed Research International 2020
[COVID-19, management, therapeutic and vaccine approaches].
Matusik É, Ayadi M, Picard N
2020
Disease severity dictates SARS-CoV-2-specific neutralizing antibody responses in COVID-19.
Chen X, Pan Z, Yue S, Yu F, Zhang J, Yang Y, Li R, Liu B, Yang X, Gao L, Li Z, Lin Y, Huang Q, Xu L, Tang J, Hu L, Zhao J, Liu P, Zhang G, Chen Y, Deng K, Ye L
Signal Transduction and Targeted Therapy 2020
Nanotheranostics against COVID-19: From multivalent to immune-targeted materials.
Hassanzadeh P
Journal of Controlled Release 2020
The potential threat of multisystem inflammatory syndrome in children during the COVID-19 pandemic.
Rothan HA, Byrareddy SN
Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology 2020
A comprehensive, longitudinal analysis of humoral responses specific to four recombinant antigens of SARS-CoV-2 in severe and non-severe COVID-19 patients.
Chen Y, Tong X, Li Y, Gu B, Yan J, Liu Y, Shen H, Huang R, Wu C
PLoS pathogens 2020
Antibody-dependent enhancement of coronavirus.
Wen J, Cheng Y, Ling R, Dai Y, Huang B, Huang W, Zhang S, Jiang Y
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 2020
The Challenges of Vaccine Development against Betacoronaviruses: Antibody Dependent Enhancement and Sendai Virus as a Possible Vaccine Vector.
Zaichuk TA, Nechipurenko YD, Adzhubey AA, Onikienko SB, Chereshnev VA, Zainutdinov SS, Kochneva GV, Netesov SV, Matveeva OV
Molecular Biology 2020
Vaccines for COVID-19.
Tregoning JS, Brown ES, Cheeseman HM, Flight KE, Higham SL, Lemm NM, Pierce BF, Stirling DC, Wang Z, Pollock KM
Clinical & Experimental Immunology 2020
Update on serologic testing in COVID-19.
Krajewski R, Gołębiowska J, Makuch S, Mazur G, Agrawal S
Clinica chimica acta; international journal of clinical chemistry 2020
A 63-Year-Old Woman with a History of Non-Hodgkin Lymphoma with Persistent SARS-CoV-2 Infection Who Was Seronegative and Treated with Convalescent Plasma.
Moore JL, Ganapathiraju PV, Kurtz CP, Wainscoat B
2020
Enhanced elicitation of potent neutralizing antibodies by the SARS-CoV-2 spike receptor binding domain Fc fusion protein in mice.
Liu X, Drelich A, Li W, Chen C, Sun Z, Shi M, Adams C, Mellors JW, Tseng CT, Dimitrov DS
Vaccine 2020
Successful transfer of anti-SARS-CoV-2 immunity using convalescent plasma in an MM patient with hypogammaglobulinemia and COVID-19.
Luetkens T, Metcalf R, Planelles V, Zheng Y, Larragoite ET, Spivak ES, Spivak AM, Steinbach M, Blaylock RC, Avila SV, Hankey KG, Martins TB, Slev PR, Mannuel HD, Sajadi M, Rapoport AP, Atanackovic D
Blood Advances 2020
Yeast-expressed SARS-CoV recombinant receptor-binding domain (RBD219-N1) formulated with aluminum hydroxide induces protective immunity and reduces immune enhancement.
Chen WH, Tao X, Agrawal AS, Algaissi A, Peng BH, Pollet J, Strych U, Bottazzi ME, Hotez PJ, Lustigman S, Du L, Jiang S, Tseng CK
Vaccine 2020
A systematic review of SARS-CoV-2 vaccine candidates.
Dong Y, Dai T, Wei Y, Zhang L, Zheng M, Zhou F
Signal Transduction and Targeted Therapy 2020
Potential Challenges for Coronavirus (SARS-CoV-2) Vaccines Under Trial.
Usmani SS, Raghava GPS
Frontiers in immunology 2020
Role of Systemic and Nasal Glucocorticoid Treatment in the Regulation of the Inflammatory Response in Patients with SARS-Cov-2 Infection.
Cárdenas G, Torres-García D, Cervantes-Torres J, Rosales-Mendoza S, Fleury A, Fragoso G, Laclette JP, Sciutto E
Archives of Medical Research 2020
Systemic and mucosal antibody responses specific to SARS-CoV-2 during mild versus severe COVID-19.
Cervia C, Nilsson J, Zurbuchen Y, Valaperti A, Schreiner J, Wolfensberger A, Raeber ME, Adamo S, Weigang S, Emmenegger M, Hasler S, Bosshard PP, De Cecco E, Bächli E, Rudiger A, Stüssi-Helbling M, Huber LC, Zinkernagel AS, Schaer DJ, Aguzzi A, Kochs G, Held U, Probst-Müller E, Rampini SK, Boyman O
Journal of Allergy and Clinical Immunology 2020
Recommendations for the Diagnosis, Prevention, and Control of Coronavirus Disease-19 in Children-The Chinese Perspectives.
Fang F, Chen Y, Zhao D, Liu T, Huang Y, Qiu L, Hao Y, Hu X, Yin W, Liu Z, Jin R, Ning Q, Cheung PT, Liu C, Shu S, Wang T, Luo X
Frontiers in Pediatrics 2020
Seroprevalence of SARS-CoV-2 in Hong Kong and in residents evacuated from Hubei province, China: a multicohort study.
To KK, Cheng VC, Cai JP, Chan KH, Chen LL, Wong LH, Choi CY, Fong CH, Ng AC, Lu L, Luo CT, Situ J, Chung TW, Wong SC, Kwan GS, Sridhar S, Chan JF, Fan CY, Chuang VWM, Kok KH, Hung IF, Yuen KY
2020
Low toxicity and high immunogenicity of an inactivated vaccine candidate against COVID-19 in different animal models.
Wang ZJ, Zhang HJ, Lu J, Xu KW, Peng C, Guo J, Gao XX, Wan X, Wang WH, Shan C, Zhang SC, Wu J, Yang AN, Zhu Y, Xiao A, Zhang L, Fu L, Si HR, Cai Q, Yang XL, You L, Zhou YP, Liu J, Pang DQ, Jin WP, Zhang XY, Meng SL, Sun YX, Desselberger U, Wang JZ, Li XG, Duan K, Li CG, Xu M, Shi ZL, Yuan ZM, Yang XM, Shen S
Emerging Microbes & Infections 2020
Clinical, molecular, and epidemiological characterization of the SARS-CoV-2 virus and the Coronavirus Disease 2019 (COVID-19), a comprehensive literature review
Ortiz-Prado E, Simbaña-Rivera K, Gómez- Barreno L, Rubio-Neira M, Guaman LP, Kyriakidis NC, Muslin C, Jaramillo AM, Barba-Ostria C, Cevallos-Robalino D, Sanches-SanMiguel H, Unigarro L, Zalakeviciute R, Gadian N, López-Cortés A
Diagnostic Microbiology and Infectious Disease 2020
Fighting the Host Reaction to SARS-COv-2 in Critically Ill Patients: The Possible Contribution of Off-Label Drugs
Scala S, Pacelli R
Frontiers in immunology 2020
A potentially effective treatment for COVID-19: A systematic review and meta-analysis of convalescent plasma therapy in treating severe infectious disease
Sun M, Xu Y, He H, Zhang L, Wang X, Qiu Q, Sun C, Guo Y, Qiu S, Ma K
International Journal of Infectious Diseases 2020
Energetics and IC50 based epitope screening in SARS CoV-2 (COVID 19) spike protein by immunoinformatic analysis implicating for a suitable vaccine development
Banerjee A, Santra D, Maiti S
Journal of Translational Medicine 2020
Immune-mediated approaches against COVID-19
Florindo HF, Kleiner R, Vaskovich-Koubi D, Acúrcio RC, Carreira B, Yeini E, Tiram G, Liubomirski Y, Satchi-Fainaro R
Nature Nanotechnology 2020
Contribution of monocytes and macrophages to the local tissue inflammation and cytokine storm in COVID-19: Lessons from SARS and MERS, and potential therapeutic interventions
Jafarzadeh A, Chauhan P, Saha B, Jafarzadeh S, Nemati M
Life Sciences 2020
SARS-CoV-2-specific ELISA development
Roy V, Fischinger S, Atyeo C, Slein M, Loos C, Balazs A, Luedemann C, Astudillo MG, Yang D, Wesemann DR, Charles R, Lafrate AJ, Feldman J, Hauser B, Caradonna T, Miller TE, Murali MR, Baden L, Nilles E, Ryan E, Lauffenburger D, Beltran WG, Alter G
Journal of Immunological Methods 2020
SARS-CoV-2 neutralizing antibody levels are correlated with severity of COVID-19 pneumonia
Chen W, Zhang J, Qin X, Wang W, Xu M, Wang LF, Xu C, Tang S, Liu P, Zhang L, Liu X, Zhang Y, Yi C, Hu Z, Yi Y
Biomedicine & Pharmacotherapy 2020
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
Folegatti PM, Ewer KJ, Aley PK, Angus B, Becker S, Belij-Rammerstorfer S, Bellamy D, Bibi S, Bittaye M, Clutterbuck EA, Dold C, Faust SN, Finn A, Flaxman AL, Hallis B, Heath P, Jenkin D, Lazarus R, Makinson R, Minassian AM, Pollock KM, Ramasamy M, Robinson H, Snape M, Tarrant R, Voysey M, Green C, Douglas AD, Hill AV, Lambe T, Gilbert SC, Pollard AJ
2020
The DHODH inhibitor PTC299 arrests SARS-CoV-2 replication and suppresses induction of inflammatory cytokines
Luban J, Sattler RA, Mühlberger E, Graci JD, Cao L, Weetall M, Trotta C, Colacino JM, Bavari S, Strambio-De-Castillia C, Suder EL, Wang Y, Soloveva V, Cintron-Lue K, Naryshkin NA, Pykett M, Welch EM, O\u2019Keefe K, Kong R, Goodwin E, Jacobson A, Paessler S, Peltz SW
Virus Research 2020
COVID-19 vaccines: The status and perspectives in delivery points of view
Chung JY, Thone MN, Kwon YJ
Advanced Drug Delivery Reviews 2020
A highly immunogenic and effective measles virus-based Th1-biased COVID-19 vaccine
Hörner C, Schürmann C, Auste A, Ebenig A, Muraleedharan S, Dinnon KH III, Scholz T, Herrmann M, Schnierle BS, Baric RS, Mühlebach MD
Proceedings of the National Academy of Sciences 2020
RNA Vaccines: A Suitable Platform for Tackling Emerging Pandemics?
Sandbrink JB, Shattock RJ
Frontiers in immunology 2020
Severe Acute Respiratory Syndrome Coronavirus-2 Induces Cytokine Storm and Inflammation During Coronavirus Disease 19: Perspectives and Possible Therapeutic Approaches
Mannino F, Bitto A, Irrera N
Frontiers in pharmacology 2020
Severe Coronavirus Disease 2019 That Recovered from Respiratory Failure by Treatment That Included High-dose Intravenous Immunoglobulin
Suzuki Y, Tanino Y, Nikaido T, Minemura H, Umeda T, Rikimaru M, Onuma T, Naito S, Takiguchi Y, Tomita H, Kawamata T, Togawa R, Sato Y, Uematsu M, Morimoto J, Kitakawa K, Tsukada Y, Nakamura K, Kanemitsu K, Iseki K, Shibata Y
Internal Medicine 2020
Antibody testing for COVID-19: A report from the National COVID Scientific Advisory Panel
Adams ER, Ainsworth M, Anand R, Andersson MI, Auckland K, Baillie JK, Barnes E, Beer S, Bell JI, Berry T, Bibi S, Carroll M, Chinnakannan SK, Clutterbuck E, Cornall RJ, Crook DW, de Silva T, Dejnirattisai W, Dingle KE, Dold C, Espinosa A, Eyre DW, Farmer H, Fernandez Mendoza M, Georgiou D, Hoosdally SJ, Hunter A, Jefferey K, Kelly DF, Klenerman P, Knight J, Knowles C, Kwok AJ, Leuschner U, Levin R, Liu C, López-Camacho C, Martinez J, Matthews PC, McGivern H, Mentzer AJ, Milton J, Mongkolsapaya J, Moore SC, Oliveira MS, Pereira F, Perez E, Peto T, Ploeg RJ, Pollard A, Prince T, Roberts DJ, Rudkin JK, Sanchez V, Screaton GR, Semple MG, Slon-Campos J, Skelly DT, Smith EN, Sobrinodiaz A, Staves J, Stuart DI, Supasa P, Surik T, Thraves H, Tsang P, Turtle L, Walker AS, Wang B, Washington C, Watkins N, Whitehouse J
Wellcome Open Research 2020
Progress and Challenges in the Development of COVID-19 Vaccines and Current Understanding of SARS-CoV-2- Specific Immune Responses
Kim KD, Hwang I, Ku\u2020 KB, Lee S, Kim SJ, Kim C
Journal of Microbiology and Biotechnology 2020
Germline immunoglobulin genes: disease susceptibility genes hidden in plain sight?
Collins AM, Yaari G, Shepherd AJ, Lees W, Watson CT
Current Opinion in Systems Biology 2020
Convalescent Plasma in COVID-19
Banwait RS, Salabei JK, Fishman TJ, Iyer UG
2020
[Progress and analysis on the development of 2019-nCoV vaccine].
Kang Z, Tang M
Sheng wu yi xue gong cheng xue za zhi = Journal of biomedical engineering = Shengwu yixue gongchengxue zazhi 2020
Establishment of an African green monkey model for COVID-19
Woolsey C, Borisevich V, Prasad AN, Agans KN, Deer DJ, Dobias NS, Heymann JC, Foster SL, Levine CB, Medina L, Melody K, Geisbert JB, Fenton KA, Geisbert TW, Cross RW
2020
Yeast-Expressed SARS-CoV Recombinant Receptor-Binding Domain (RBD219-N1) Formulated with Aluminum Hydroxide Induces Protective Immunity and Reduces Immune Enhancement
Chen WH, Tao X, Agrawal A, Algaissi A, Peng BH, Pollet J, Strych U, Bottazzi ME, Hotez PJ, Lustigman S, Du L, Jiang S, Tseng CT
2020
Detection of antibodies to the SARS-CoV-2 spike glycoprotein in both serum and saliva enhances detection of infection
Faustini SE, Jossi SE, Perez-Toledo M, Shields AM, Allen JD, Watanabe Y, Newby ML, Cook A, Willcox CR, Salim M, Goodall M, Heaney JL, Marcial-Juarez E, Morley GL, Torlinska B, Wraith DC, Veenith TV, Harding S, Jolles S, Ponsford MJ, Plant T, Huissoon A, O\u2019Shea MK, Willcox BE, Drayson MT, Crispin M, Cunningham AF, Richter AG
2020
COVID-19 neutralizing antibodies predict disease severity and survival
Garcia-Beltran WF, Lam EC, Astudillo MG, Yang D, Miller TE, Feldman J, Hauser BM, Caradonna TM, Clayton KL, Nitido AD, Murali MR, Alter G, Charles RC, Dighe A, Branda JA, Lennerz JK, Lingwood D, Schmidt AG, Iafrate AJ, Balazs AB
2020
Severe Acute Respiratory Syndrome
DS Hui, A Zumla
Infectious Disease Clinics of North America 2019
Pulmonary surfactant: an immunological perspective
ZC Chroneos, Z Sever-Chroneos, VL Shepherd
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology 2009

← Previous 1 2 3 4 5 6 … 22 23 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts